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Abstract 
ARDIOVASCULAR diseases are an increasing source of concern in modern societies due to 
their increasing prevalence and high impact on the lives of many people. Monitoring 
cardiovascular parameters in ambulatory scenarios is an emerging approach that can provide better 
medical access to patients while decreasing the costs associated to the treatment of these diseases. 
This work analyzes systems and methods to measure time intervals between the 
electrocardiogram (ECG), impedance plethysmogram (IPG), and the ballistocardiogram (BCG), 
which can be noninvasively obtained at the limbs in ambulatory scenarios using simple and cost-
effective systems, to assess cardiovascular intervals of interest in research and clinical practice, such 
as the pulse arrival time (PAT), pulse transit time (PTT), or the pre-ejection period (PEP).  
The first section of this thesis analyzes the impact of the signal acquisition system on the 
uncertainty in timing measurements in order to establish the design specifications for systems 
intended for that purpose. The minimal requirements found are not very demanding yet some 
common signal acquisition systems do not fulfill all of them. On the other hand, some capabilities 
typically found in signal acquisition systems could be downgraded without worsening the 
uncertainty of timing measurements hence resulting in more cost-effective designs. This section is 
also devoted to the design of systems intended for timing measurements in ambulatory scenarios 
according to the specifications previously established. The systems presented have evolved from 
the current state-of-the-art and are designed for adequate performance in timing measurements 
with a minimal number of active components, which results in a lower cost and longer battery life. 
The second section is focused on the measurement of time intervals from the IPG measured 
from limb to limb, which is a signal that until now has only been used to monitor heart rate and 
whose detailed physiological origin was unknown. A model to estimate the contributions to the 
time events in the measured waveform of the different body segments along the current path from 
geometrical properties of the large arteries is proposed, and the simulation under blood pressure 
changes suggests that the signal is sensitive to changes in proximal sites of the current path rather 
than in distal sites. Experimental results show that the PAT from the R wave of the ECG to the 
hand-to-hand IPG, which is obtained from a novel four-electrode handheld system, is strongly 
correlated to changes in the PEP whereas the PAT from the R wave of the ECG to the foot-to-
foot IPG shows good performance in assessing changes in the femoral PAT. Therefore, limb-to-
limb IPG measurements significantly increase the number of time intervals of interest that can be 
measured at the limbs since the signals deliver information from proximal sites complementary to 
that of other measurements typically performed at distal sites. 
The next section is devoted to the measurement of time intervals that involve different waves 
of the BCG obtained in a standing platform and whose origin is still under discussion. From the 
relative timing of other physiological signals, it is hypothesized that the IJ interval of the BCG is 
sensitive to variations in the PTT. Experimental results show that the BCG I wave is a better 
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surrogate of the cardiac ejection time than the widely-used J wave despite of the lower signal-to-
noise ratio (SNR) of the I wave, which is also supported by the good correlation found between the 
IJ interval and the aortic PTT. Finally, the novel time interval from the BCG I wave to the foot of 
the IPG measured between feet, which can be obtained from the same weighing scale than the 
BCG, shows good performance in assessing the aortic PTT. The results presented reinforce the 
possible role of the BCG as a tool for ambulatory monitoring since the main time intervals targeted 
in this thesis can be obtained from the timing of its waves. 
Even though the methods described were tested in small groups of subjects, not larger than 14, 
the results presented in this work show the feasibility and potential of several time interval 
measurements between the proposed signals that can be performed in ambulatory scenarios, 
provided the systems intended for that purpose fulfill some minimal design requirements. 
 
Keywords: Ambulatory measurements, electrocardiogram (ECG), impedance plethysmogram 
(IPG), ballistocardiogram (BCG), physiological instrumentation, pulse arrival time (PAT), pulse 
transit time (PTT), pre-ejection period (PEP), RJ interval, RI interval, IJ interval. 
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Chapter 1 
Motivation and objectives 
ARDIOVASCULAR diseases are the leading cause of death in the world. According to the 
most recent report of the World Health Organization (WHO) [1], 17.3 million people died 
from it in 2008, which represents 1 in every 3 total deaths, and this number is expected to raise up 
to 23.3 million in 2030. However, a large proportion of patients still remain undiagnosed until the 
last stages of disease, when they become symptomatic and require admission into hospitals and 
costly aggressive treatments such as surgery or transplantation. In this scenario, healthcare systems 
are shifting its focus to preventive therapies, which have the greatest potential to inverse the 
progression of the disease, reduce the number of hospitalizations, and decrease healthcare costs [2]. 
Besides, early detected diseases can be treated with softer therapies, such as pharmacotherapy and 
habit changes, that have a lesser impact on the patient lifestyle. 
Nevertheless, the cost-effectiveness of preventive therapies has long been debated because 
whereas some of them save more money than they cost, others do not [3]. Screenings can help in 
reducing costs by identifying individuals that can benefit from preventive therapies but most of the 
current methods to evaluate the performance of the cardiovascular system rely on the availability of 
limited resources such as expensive equipment or highly-specialized staff. For this reason, regular 
screenings in large population groups are unsustainable by healthcare systems, and these are 
currently being limited to simple and affordable regular controls of blood pressure (BP), cholesterol 
and triglycerides, body weight, blood glucose, and lifestyle habits in individuals with a high number 
of risk factors.  
If this rising trend is expected to be reversed, traditional approaches must be revised and 
discussed. The development of new cost-effective screening approaches, which has been recently 
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2        Assessment of trends in the cardiovascular system 
included in the top-five research priorities in cardiovascular diseases [4] by the WHO, is the key to a 
more effective and accessible medical treatment of cardiovascular diseases while reducing the 
always significant medical costs.  
1.1. Measurement of cardiovascular parameters in ambulatory scenarios 
The measurement of physiological parameters in ambulatory scenarios from cost-effective 
devices has become popular in the last decades and fits the requirements for effective screenings. 
The aim of this approach is to provide patients with affordable tools to perform regular fast checks, 
looking for physiological changes indicating deterioration or early signs of a disease, in the same 
way that millions of people regularly keep track of their body weight with home weighing scales. In 
addition, the regular measurement of physiological parameters in ambulatory scenarios has also 
potential interest for monitoring chronically ill patients, recovery after surgery, or fitness.  
Compared to traditional measurements performed in hospitals, this new approach has the 
following advantages: 
- Scalability: The cost of the measurement device, including its operation and maintenance, 
is lower and can even be assumed by the patient. 
- Effectiveness: Screenings can be performed more frequently, which leads to early 
detections. 
- Optimization: Some critical and expensive resources such as devices, personal, and 
accommodation are released for other uses. 
- Comfort: The total amount of displacements to medical facilities is reduced and most of 
the measurements are performed in a more comfortable environment. 
On the other hand, these measurements are subjected to some additional requirements: 
- Noninvasiveness: Any excessive discomfort or embarrassment to the patient should be 
avoided in order to ease frequent use. 
- Simplicity: The procedure should be simple enough to be understood and reproduced 
without any error by users without any specific training. 
- Cost-effectiveness: The cost should be affordable for healthcare systems or even 
particulars in order to reach a broad population group. 
Focusing on cardiovascular parameters, the existing technologies can be classified according to 
the schema shown in Fig. 1.1. 
       
   - Invasive     
Measurement 
technologies 
      
 - Imaging 
   - Noninvasive     - Optical 
     - Surface signals   - Electrical 
       - Mechanical 
       
Fig. 1.1.  Classification of technologies to obtain cardiovascular parameters. 
  
 
3 Motivation and objectives 
Invasive measurements are performed with sensors placed inside the body of the patient, via 
catheterization, endoscopy, or subdermal implants. The cost of these measurements is high due to 
the requirement of specialized operators and sanitized environments. The discomfort of the patient 
is also often high, as the placement of some sensors may require surgical procedures, anesthesia, or 
both. 
Imaging measurements, such as ultrasound echography, magnetic resonance, or x-ray, are 
noninvasive but still require costly devices operated by specialized staff. 
The most common surface optical measurement is the photoplethysmogram (PPG) [5], which 
is the recording of changes in transmitted or absorbed light in superficial tissues as a result of 
changes in blood perfusion. The sensor must to be preferably placed above a superficial artery and 
some typical measurement sites are the fingers and the earlobe, although the signal can also be 
obtained from other places, such as the carotid artery, femoral artery, or the forehead, with an 
accurate placement of the sensor performed by a specialist. 
Two surface electrical measurements that can deliver information about cardiovascular function 
are the electrocardiogram (ECG) [6] and the impedance plethysmogram (IPG) [7]. The ECG is the 
recording of the electrical activity of the heart and it can be measured differentially from several 
standardized points on the body surface. Further, the signal can be obtained from other non-
standard sites, such as between feet, although these may pose some challenges such as a very small 
amplitude and higher electromyogram (EMG) level. The IPG is the recording of volumetric-related 
changes in tissue conductivity due to cardiovascular activity. Unlike the ECG, which is passively 
recorded, the IPG requires the injection of a high-frequency current and it can theoretically be 
measured from any pair of points on the body surface.  
Mechanical surface measurements are for example the ballistocardiogram (BCG) [8], 
phonocardiogram (PCG) [9], signals from pressure pulse transducers (PPT) [10] and the 
seismocardiogram (SCG) [8]. The BCG is the recording of forces related to cardiac ejection of 
blood and some modern systems are usually built to record its longitudinal component from the 
strain gauges of a weighing scale. The PCG is the recording of cardiac vibrations in the audible 
band (40-440 Hz) from a noninvasive and cost-effective microphone fixed on the chest, whose 
placement requires some skill. PPT record changes of pressure due to vascular activity on 
superficial arteries and can be noninvasively acquired from cost-effective sensors although its 
placement, above a superficial artery with a solid tissue such as bone below to assure mechanical 
stability, requires a skilled operator and limits the number of available measurement sites. Finally, 
the SCG is the recording of chest vibrations in the infrasonic band (0-30 Hz) due to cardiac activity 
with an accelerometer attached to the chest. 
Table 1.1 summarizes these technologies and its fit to the requirements for the measurement of 
cardiovascular parameters in ambulatory scenarios previously stated. 
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Table 1.1.  Technologies for the measurement of cardiovascular parameters and its fit to ambulatory 
scenarios. 
 Technology examples Noninvasive Simple Cost-effective 
Invasive  Catheterization, endoscopy    
Imaging Echography, MRI, x-ray    
Surface optical PPG    
Surface electrical ECG    
IPG    
Surface mechanical BCG    
PCG    
PPT    
SCG    
 
The PPG, ECG, IPG, BCG, and the SCG are the most suitable technologies for the 
measurement of cardiovascular parameters in ambulatory scenarios. However, four additional 
points that limit the range of suitable technologies have been considered in this thesis. 
First, the measurement sites have been limited to the limbs, i.e hands and feet. Measurements 
on such areas do not require removing excessive amounts of clothing, as hands are usually exposed 
and feet are easily accessible by removing shoes and socks, hence these are less invasive for the 
subject and can be faster performed. Further, some signals such as the BCG or the IPG can be 
measured without removing socks or even shoes in the case of the BCG. While the ECG, PPG, 
IPG, and the BCG can be obtained at the limbs, SCG recordings require a sensor placed on the 
chest, preferably without clothing and strapped with an elastic band or attached with an adhesive, 
which is uncomfortable and time-consuming, and makes the measurement less fitted to the 
previously stated requirements. 
Second, the PPG and the IPG reflect volumetric changes in blood vessels due to cardiovascular 
activity hence it could be assumed that the signals are to some extent interchangeable. However, 
there is evidence that the contact pressure of the PPG sensor can affect the obtained waveform [11] 
and introduce shifts on the measured features [12]. Since the underlying mechanisms of both 
signals are not fully understood yet, the performance of the IPG as surrogate of the PPG, which 
has received most of the attention in research and clinical practice [5], has scientific interest by 
itself. Further, IPG systems are more cost-effective since the photo emitter and receiver pair is 
replaced by inexpensive dry electrodes. These can be easily embedded in any surface, thus 
providing better integration with existing objects such as portable devices or furniture, and can be 
easily integrated with other electrode-based systems, such as ECG or other IPG systems, to reduce 
the overall number of electrodes required. Therefore, the IPG constitutes a better option for 
systems intended to operate in ambulatory scenarios. 
Third, the IPG measured from limb to limb [13] instead of along a single blood vessel is better 
suited to ambulatory scenarios since two electrodes on each hand or feet are easier to contact with 
than four in a single hand or feet. However, to the best of our knowledge, the physiological basis of 
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the limb-to-limb IPG has not yet been discussed although it is plausible that the signal can deliver 
complementary information to the PPG or the local IPG since it is sensitive to changes along the 
whole current path besides of local ones. 
Finally, the high levels of EMG compared to the amplitude of the ECG typically found on 
ECG recordings obtained at the feet [14] makes the measurement of beat-to-beat features very 
challenging even in the best scenarios. The ECG is easier to obtain at the hands and can be 
integrated into a weighing scale through a handle bar or similar [15].  
In consequence, the technologies for the measurement of cardiovascular parameters better 
suited to the previously stated requisites are the ECG, local IPG, limb-to-limb IPG, and the 
longitudinal BCG. Fig. 1.2 shows the signals and the sites where these will be obtained in this 
thesis. 
 
Fig. 1.2.  Selected signals and sites of interest for ambulatory measurement of cardiovascular 
parameters. 
The targeted signals can be obtained at the limbs with simple, noninvasive, and cost-effective 
devices hence they are especially fitted to the measurement of cardiovascular parameters in 
ambulatory scenarios. 
1.2. Time intervals to assess trends in the cardiovascular system 
A biomedical signal can be defined as a time-varying quantity that carries information about a 
biomedical process. Although some useful information can be extracted from the waveform 
amplitude or morphology, time-domain measurements are typically better suited to the 
particularities of ambulatory scenarios, which are usually performed in less controlled environments 
where the recorded signals include more noise and artifacts than in clinical measurements. Then, 
events in the time domain are easier to analyze than amplitude or morphology features, and the 
measurements can be performed with higher accuracy. Besides, time-domain measurements do not 
require normalization, which is a critical problem for several biomedical signals and especially in 
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ambulatory scenarios, where a wrong sensor placement or an excessive electrode unbalance can 
lead to an unpredictable signal distortion. Further, measurements on the time domain can be 
performed not only in a given signal but also between different signals that reflect different 
physiological processes, to exponentially increase the potential of measuring cardiovascular 
parameters of interest. 
The measurement of time intervals between electrical and mechanical signals to assess the 
performance of the cardiovascular system has been explored since long ago. The measurement of 
the pressure pulse propagation through the arterial tree is nowadays the most simple, noninvasive, 
robust, and reproducible method to evaluate the status of the arterial walls [16]. On each heartbeat, 
the blood ejected by the heart causes an increase of arterial pressure that propagates through the 
arterial tree from proximal to distal sites. The velocity of this pulse, the so-called pulse wave 
velocity (PWV), is related to the stiffness of the arterial walls and can be measured by dividing the 
estimated distance between these points by the difference of time arrival at two sites, the so-called 
pulse transit time (PTT) [17]. As volume and flow are in phase on early waveform features such as 
the foot or the upstroke, the arrival of the pressure pulse can be measured from any device able to 
measure these quantities, although PPG is the most widely used signal for that purpose due to its 
simplicity.  
In order to get accurate PTT values, the measurement sites should be separated as much as 
possible but proximal arteries are not easily accessible. For this reason, the proximal pressure pulse 
is sometimes replaced by the R wave of the ECG, which means that the measured interval, named 
pulse arrival time (PAT) to differentiate it from the PTT, partially includes the time between the 
electrical onset of the heart and the aperture of the aortic valve, which marks the beginning of 
cardiac ejection and propagation of the pressure pulse. This electromechanical delay, named the 
pre-ejection period (PEP), starts by definition from the beginning of the QRS complex, the Q 
wave, and has also great interest by itself as it can be used to evaluate the health status of the heart 
[18]. Fig. 1.3 shows the PTT, PAT, and the PEP measured from the ECG, aortic BP, and the finger 
BP.  
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Fig. 1.3.  PTT, PAT, and PEP measured from representations of the ECG, aortic BP, and the finger 
BP. 
These three time intervals, the PTT, PAT, and the PEP, are widely used in research and clinical 
practice since several cardiovascular parameters of interest can be obtained from them. The PTT is 
a direct indicator of arterial stiffness, which is related to several factors such as ageing or 
hypertension [15] and associated to many cardiovascular diseases including stroke and myocardial 
infarction [16]. The carotid-to-femoral PTT measurement, the so-called aortic PTT, is currently the 
gold standard for the assessment of regional arterial stiffness [17] and it has been included in the 
“2013 ESC/ESH guidelines for the management of arterial hypertension” [18], although similar 
information can be delivered from PTT measurements obtained at other sites such as the ankle-
wrist segment [19]. The PTT can also be used to monitor peripheral arterial diseases in distal sites 
caused by pathologies such as diabetes [20], and BP in ambulatory scenarios [19]. 
The PAT is easier to measure than the PTT as the proximal pressure pulse waveform, which 
can be difficult to obtain, is replaced by the easily-obtained ECG. Even though in certain situations 
the influence of the PEP must be considered [20], the PAT has proved to be useful for the 
detection of sleep disorders [21] and autonomic nervous system activation [22], and for the tracking 
of fast beat-to-beat changes in BP using intermittent [23] or one-point [24] calibration. Further, the 
PTT can be derived from two PAT measurements sequentially obtained at different sites [25]. 
The PEP can be used to monitor left ventricular contractility [26], which provides valuable 
information about myocardial performance, and sympathetic activity under stable conditions of 
preload and afterload [27]. Besides, abnormal interval durations can be used to diagnose various 
diseases such as left ventricular muscular failure, left bundle branch block, or aortic valve disease 
[28]. 
These three time intervals, the PAT, PTT, and the PEP, are excellent indicators of 
cardiovascular performance and can potentially be obtained from the signals here proposed hence 
  
 
8        Assessment of trends in the cardiovascular system 
these are especially fitted to be measured in ambulatory scenarios for the assessment of trends in 
the cardiovascular system. 
1.3. Overview of current technologies to obtain the ECG, IPG, and the BCG 
Nowadays, several systems able to acquire the ECG, IPG, and the BCG are being used to 
assess cardiovascular parameters in research and clinical practice from time intervals between their 
waves. However, many of those systems have been designed for general purposes since it is 
commonly assumed that systems suitable for medical diagnose do not limit the accuracy of time-
interval measurements and that the uncertainty in cardiovascular parameters assessed from time 
intervals is often limited by other factors, e.g. the uncertainty of the aortic length in PWV 
measurements [29]. For this reason, the uncertainty of cardiovascular parameters assessed from 
timing measurements is generally reported in comparison to a reference method [29][30][31][32] 
whereas the uncertainty of the individual timing measurements, which can be affected by the signal 
acquisition system, is omitted.  
While the effect of the sampling frequency of ECG systems in heart rate variability indexes has 
been briefly analyzed [33], the effect of several parameters such as the phase response of analog 
filters, noise level, sampling frequency, or the resolution of the analog-to-digital converter (ADC) 
that have been studied for magnitude-domain measurements has not been quantified for the 
measurement of time intervals in the proposed signals despite of its scientific interest. A detailed 
analysis of these uncertainties is fundamental for a better understanding of the reported 
uncertainties in time interval measurements and could be helpful in the design of cost-effective 
acquisition systems intended to be used in broad population groups. 
Further, many of the measurement systems being used nowadays are legated from old designs 
intended for purposes other than time interval measurement. Even though these designs can still 
perform well, the inclusion of parts unsuited to current measurement scenarios results in an 
unjustified increase of cost and power consumption with a null impact on improving the 
measurement uncertainty. Therefore, it is mandatory to review the current state-of-the-art of 
instrumentation to identify the designs that provide the best performance in ambulatory scenarios. 
1.3.1. The ECG in ambulatory scenarios 
The measurement of the ECG in ambulatory scenarios has been widely explored in the last 
decades up to the point that several technologies that include Holter monitors, loop recorders, and 
event recorders are commercially available nowadays [34]. These systems follow a specific standard 
for ambulatory ECG devices [35], which allows some minor waveform distortions as compared to 
diagnostic ECG devices [36] as tradeoff for better performance against noise, interference, and 
artifacts commonly found in ambulatory recordings.  
Whereas Holter monitors and loop recorders are designed to be worn for long time periods, 
event recorders are intended to perform fast short measurements when the patient is symptomatic 
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hence these are better suited to screenings or regular checks. Event recorders are typically designed 
to obtain the ECG at the hands by avoiding the use of electrolytic gel, which is commonly used in 
clinic ECG systems to increase skin conductivity, reduce contact losses due to movements, and 
absorb surface irregularities such as hair. Instead, the ECG is obtained from metallic surfaces 
contacted with the palms or the fingers, as in the example device shown in Fig. 1.4. 
 
Fig. 1.4.  ECG event recorder HeartCheckTM Pen, from CardioComm Solutions Inc. 
Further, the ECG can be measured through clothing [37] and even insulating layers such as 
plastic, which increases the number of design options. Although wet electrodes are preferred in 
clinical practice, properly designed systems using dry or insulated electrodes can show similar or 
even better performance [38]. However, systems that use insulated electrodes usually suffer from 
long settling time after saturation [39], which is common in ambulatory scenarios as a result of 
motion artifacts, and the recordings can be affected by microphonics [40]. 
Several systems are similarly designed to obtain the ECG from the hands and only differ in the 
measurement sites, which can be the indexes [41], thumbs [42], palms [43], fingertips [44], or a 
combination of the palm and the index of the opposite hand [45]. Another option is to measure the 
ECG from a system embedded in a wristwatch [46], with an electrode in the wrist and another 
electrode contacted with a finger of the opposite hand. Finally, some alternative designs use 
electrodes embedded in common objects or furniture frequently contacted by hands such as a 
steering wheel or the armrests of a chair [47]. 
1.3.2. The IPG in ambulatory scenarios 
As a result of the popularity of the PPG, the IPG has been relegated to a second plane as tool 
to obtain pressure-pulse waveforms in research and clinical practice. However, impedance 
measurements are still common practice for the diagnosis of deep vein thrombosis from blood flow 
measurements in limbs [48] and for the evaluation of cardiac function by impedance cardiography 
(ICG) [49], which is routinely used in intensive care units. 
The PPG is the most used technology to record pressure-pulse waveforms from limbs in 
clinical settings and its utility as a cardiovascular monitoring tool has been widely proved [5]. In 
consequence, the surrogate use of the IPG should show similar performance, as both signals reflect 
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plethysmographic changes in arteries. However, although the PPG correlates well with blood 
volume changes because these increase blood density and the path of the light through the tissues, 
other factors such as the flow-dependent orientation of the erythrocytes have influence on the 
waveform and can hardly be differentiated [50]. On the other hand, flow-related changes of blood 
resistivity in large arteries are estimated to represent about 21.5 % of the measured impedance 
change in the IPG [51], which is enough to change the morphology of the impedance waveform. 
Further, the contact pressure of the PPG sensor can distort the obtained waveform [11] and shift 
the measured features [12]. In such circumstances, the performance of the IPG as a surrogate of 
the PPG could be questionable hence its evaluation has scientific interest. 
In [52] the IPG is obtained at the arm and the forearm to assess the PAT, and the correlation 
with a simultaneous PAT measurement obtained from a finger PPG is strong. Several systems 
obtain two IPG waveforms along a limb to measure the PTT [53][54][55][56] by injecting a current 
from two distanced electrodes and measuring impedance in a proximal and a distal site between the 
injection electrodes. However, this measurement is unpractical in hands or feet as the measurement 
uncertainty is high due to the short distance between electrodes. Besides, a simultaneous contact 
with the six electrodes is difficult and can lead to false contacts and motion artifacts. Finally, in [57] 
the IPG waveform is obtained at the wrist from a handheld devices to detect heart rate. Some 
modern wristwatches intended for health monitoring are able to acquire this signal and can 
potentially measure the PAT as they also obtain the ECG, as in the example device shown in Fig. 
1.5. 
 
Fig. 1.5.  Multi-sensor wearable platform SimbandTM, from Samsung Electronics Co. 
Other IPG measurements at the limbs are performed between distal sites instead of along a 
single vessel, which yields better signals in terms of signal-to-noise ratio (SNR). The IPG is used to 
detect the pressure-pulse waveform at the root of the aorta from a whole-body impedance 
measurement [58] performed from wrists to ankles that is assumed to have a similar performance 
than the impedance cardiogram (ICG) [49]. However, the influence of impedance changes in limbs, 
which affect other whole-body impedance measurements [59], is neglected although the systematic 
underestimation of PTT reported when using the whole-body impedance measurement as a 
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proximal signal suggests that the waveform is delayed with respect to the ICG waveform and 
therefore reflects changes in more distal sites.  
Other measurements at the limbs performed in distal sites can potentially reflect changes in 
proximal sites and be easily integrated in daily-used devices. The IPG is obtained from foot to foot 
in [13] and [60] to detect heart rate, and in [15] to increase the reliability in heartbeat detection from 
the BCG. Although the physiological basis of this signal is not reported, the signal could be 
sensitive to the arrival of the pressure pulse at the abdomen as the current flows from leg to leg 
through it. Analogously, the measurement of impedance from hand to hand, which is described in 
[61] although no application is reported, could be sensitive to volume changes in the arteries of the 
thorax that reflect the earliest volume changes caused by cardiac ejection. Therefore, the 
physiologic basis of both limb-to-limb IPG measurements is unexplained and has scientific interest 
as they can deliver complementary information to other signals obtained at distal sites such as the 
ECG, PPG, or other local IPG measurements. 
1.3.3. The BCG in ambulatory scenarios 
Even though the first observations of the BCG were performed in 1877 [62] and several 
measurement systems were developed in the late 1930s [63], the signal never became common in 
medical practice because it required cumbersome measurement setups, like that shown in Fig. 1.6, 
and the cardiovascular parameters obtained from it could be alternatively obtained from other 
methods such as the ICG and, later, Doppler ultrasound. 
 
Fig. 1.6.  Ballistocardiograph from the 50s, adapted from [64]. 
Nevertheless, several simple and cost-effective BCG acquisition systems have been developed 
in the last years, prompting a new interest on this signal. Nowadays, the BCG is obtained from 
chairs [65], weighing scales [66], beds [67], and accelerometers [68]. Among these, weighing scales 
and other platforms are the most suitable for short periodic measurements because BCG 
recordings in chairs are highly influenced by changes in the subject position and systems to record 
the BCG in beds are cumbersome and most of them do not record the signal along the most 
interesting longitudinal axis.  
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The longitudinal BCG acquired from a weighing scale is used to measure heart rate [66] and has 
been proposed to measure cardiac output [69]. Since the BCG waves are caused by cardiac ejection, 
most of the research effort is focused on the measurement of the time between the ECG R wave 
and the BCG J wave, the so-called RJ interval, to assess cardiovascular parameters modulated by 
the PEP [70] and contractility [71], which is inversely proportional to the PEP under stable 
conditions of preload and afterload. The RJ interval is also used to monitor changes in systolic BP 
[14], which has a strong correlation with PEP in short effort tests [72]. However, the J wave is 
delayed by about 100 ms with respect to the upstroke of the aortic pressure that marks the end of 
the PEP, as shown in Fig. 1.7.  
 
Fig. 1.7.  PEP and RJ interval measured from representations of the ECG, aortic BP, and the BCG. 
Even though the physiological basis of the BCG was fully described for systems weakly 
coupled to the environment such as hanging beds [73], which record the ultra-low-frequency BCG 
[8], it is not possible to elucidate if any of the waves measured from modern systems strongly 
coupled to the environment such as weighing scales reflect the opening of the aortic valve. For this 
reason, the J wave is usually taken as a reference for being the greatest feature in the BCG 
waveform and therefore the wave with the highest SNR. However, the relative timing of the BCG 
with respect to other physiological waveforms suggests that the J wave is influenced by events 
caused by the propagation of the pressure pulse along the arterial tree and earlier waves could be 
more closely related to cardiac ejection. Since the H wave, whose use to assess the PEP was 
suggested in [74] and is nearly simultaneous with the aortic valve opening, is attributed to 
ventricular movements due to its absence in recordings without ventricular contraction [75], only 
the I wave seems to be more closely related to cardiac ejection than the J wave. In consequence, the 
time interval from the ECG R wave to I wave could show better performance in assessing the PEP 
than the RJ interval whereas the higher dependency of the J wave on events in distal sites suggests 
that the IJ interval could be used to assess the PTT from the I wave. 
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Further, the measurement of time intervals between the BCG and pressure-pulse signals that 
can be obtained in a weighing scale, such as the IPG, has not been fully explored, even though 
some systems reported are theoretically capable of performing these measurements [15]. The I 
wave of the BCG has been very recently used in [76] as a proximal signal to measure the PTT to 
the finger, which showed a moderately strong correlation to diastolic BP. Since the BCG waveform 
is caused by cardiac ejection, it is reasonable to assume that the interval from the BCG to a distal 
pressure-pulse signal obtained at the feet includes the aortic PTT and could be used for its 
assessment.  
1.4. Objectives and their interest 
The aim of this thesis is to prove that it is possible to reliably assess changes in the 
cardiovascular system from time intervals between physiological signals obtained at the limbs. The 
PEP, PAT, and the PTT have been identified as useful markers of cardiovascular performance that 
can be noninvasively measured in ambulatory scenarios from the ECG, IPG, and the BCG 
obtained at the limbs. The main research interests of this endeavor identified from the state of the 
art are: 
1. To establish the requirements for ECG, IPG, and BCG data acquisition systems 
intended for the measurement of time intervals. Most of the systems currently used to 
acquire signals for time interval measurements have not been specifically designed for that 
purpose. The effect of several parameters of data acquisition systems such as the phase 
response of analog filters, noise level, sampling frequency, or the resolution of the ADC 
that can limit the uncertainty of timing measurements should be studied and quantified. 
The results will help in identifying the sources of uncertainty in timing measurements and 
help in the design of cost-effective systems intended for timing measurements.  
2. To design and characterize systems intended to obtain the ECG, local IPG, limb-
to-limb IPG, and BCG for the measurement of time intervals in ambulatory 
scenarios. Several systems currently used to measure the ECG, local IPG, limb-to-limb 
IPG, and the BCG have evolved from legacy designs intended for other purposes. The 
designs should be reviewed and adapted according to the findings of the first objective, to 
be cost-effective and reliable in ambulatory scenarios. Further, the performance of the 
systems designed compared to other reference systems for the measurement of time 
intervals is also relevant. Some examples of particular interest are the performance of 
ambulatory ECG systems compared to diagnostic ECG systems or the performance of the 
IPG as a surrogate of the PPG. The systems developed will constitute a reference for 
further timing measurements. 
3. To evaluate the performance of the IPG measured between hands and between feet 
for detecting the pressure pulse arrival at proximal sites. The IPG from limb to limb 
can potentially reflect changes in proximal sites even though it is measured in distal sites. 
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However, a model is still required to understand the physiological basis of the signal and 
predict its behavior. After that, time intervals measured between this signal and other 
signals measured at the limbs should be able to assess some of the parameters of interest. 
The results will help in gaining knowledge about this signal to fully explore its potential. 
4. To evaluate the influence of BCG waveform changes in time intervals measured 
from its waves. The I wave of the BCG is more likely related to aortic ejection than the J 
wave hence the RI interval should perform better in assessing the PEP than the RJ interval. 
In consequence, timings between the I wave and other waves of the BCG that reflect later 
events of the pressure-pulse propagation through the arterial tree should be correlated to 
changes in the PTT. Finally, time intervals measured from the I wave to other distal signals 
obtained from a compact system embeddable in a weighing scale have potential interest as 
these are also influenced by the PTT. The results will help in increasing the capabilities of 
weighing scales intended for periodic monitoring of cardiovascular parameters. 
1.5. Overview of this document 
Chapter 2 is focused on the instrumentation developed to obtain the selected signals in 
ambulatory scenarios. Section 2.1, 2.2, and 2.3 are devoted to the ECG, IPG, and the BCG, 
respectively. Each section starts with an introductory background of the physiological basis of the 
signal followed by a short overview of the instrumentation to obtain it. After that, several factors 
that limit the uncertainty in timing measurements from the signal are described and characterized. 
Afterwards, a data acquisition system is proposed and characterized with respect to other reference 
measurement systems. Finally, section 2.4 describes the data acquisition system and other systems 
used throughout the experiments to obtain several reference physiological signals. 
Chapter 3 is focused on the IPG measured form limb to limb. Section 3.1 gives an introduction 
to IPG measurements performed from distal sites. Section 3.2 proposes a model to describe the 
physiological basis of the signal generated from the available physiological data. Section 3.3 
evaluates the model for measurements from hand to hand by analyzing the performance of the 
signal in assessing changes in the PEP from a novel four-electrode handheld system able to obtain 
the IPG and the ECG. Section 3.4 evaluates the model for foot to foot measurements by analyzing 
the performance of the signal, combined with the ECG, in assessing changes in the femoral PAT. 
Chapter 4 deals on time intervals measured between ECG and BCG waves, inside BCG waves, 
and between the BCG and the IPG. Section 4.1 describes the possible origin of the BCG waves 
and the time distances between them to support the hypotheses later tested. Section 4.2 compares 
the performance of the RI and RJ intervals in assessing cardiac ejection. Section 4.3 analyzes the 
performance of time intervals measured between the I wave and the J wave in assessing the PTT. 
Finally, section 4.4 describes and characterizes a novel system to measure the aortic PTT from the 
BCG and the foot-to-foot IPG embedded in a weighing scale. 
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Chapter 5 concludes the work with a summary of the contributions, some of their possible 
implications, and some guidelines for future work. 
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Chapter 2  
Physiological signals and 
instrumentation 
HE ECG, IPG, and the BCG have been previously identified as some of the physiological 
signals best fitted to the assessment of cardiovascular parameters from time interval 
measurements in ambulatory scenarios. However, the effect of several factors intrinsic to the 
signals or the measurement system that can influence the measurement of time intervals, such as 
the phase response of analog filters, sampling frequency, noise level, or the resolution of the ADC, 
has not yet been characterized. Further, most of the systems currently being used to obtain them 
were not originally designed for that purpose and some of their features could be unsuited to 
modern scenarios. This chapter provides an introductory background of the physiological basis of 
the signals, analyzes the factors that can influence the measurement uncertainty of time intervals, 
and describes the instrumentation designed for their measurement in ambulatory scenarios. 
2.1. The electrocardiogram (ECG) 
The heart is responsible of pumping blood through the vascular tree to transport oxygen, 
nutrients, and other substances to all the organs and tissues of the body while taking away waste 
products and regulating the body temperature. The heart is a muscular organ, composed by four 
chambers separated by valves, which need to be activated in a given order to pump blood 
continuously to the pulmonary and systemic circuits. The ECG is the recording of the electrical 
potentials originated during the simultaneous activation of the cardiac cells on different areas of the 
myocardium, and can be measured either on the heart surface or the body surface. These electrical 
T 
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potentials were first observed in 1887 by Waller [77] and later recorded by Einthoven in 1902 [78], 
which named the recording the ECG. Since then, it has become the main tool for heart disease 
diagnosis as it can be noninvasively acquired from electrodes placed on the body surface and its 
waveform reflects several pathologies such as myocardial infarction, dysrhythmias, or pulmonary 
embolism among others. 
The electrical activity of the heart is traditionally modeled as a current dipole source, whose 
position, orientation, and magnitude define a cardiac vector. The measured potentials are the 
projection of this cardiac vector into a lead vector, defined by the position of the measurement 
electrodes on the body surface. A standard ECG recording is composed by 12 leads, obtained from 
10 electrodes placed on different points of the body surface [36], that measure complementary 
projections of the cardiac vector. Fig. 2.1 shows a representation of an ECG waveform with its 
main waves. 
 
Fig. 2.1.  Representation of the ECG waveform and its main waves. 
ECG waves are conventionally named by consecutive letters starting by the P wave, which 
marks the onset of the electrical activity and is caused by atria depolarization. Typical P waves last 
from 80 ms to 100 ms and their amplitude is less than 300 µV. Afterwards the electrical impulse is 
delayed from 120 ms to 200 ms in the sinoatrial node before continuing with the depolarization of 
the ventricles, marked by the QRS complex. In non-pathological hearts, the QRS complex lasts 
from 60 ms to 100 ms and constitutes the largest amplitude of the ECG waveform, reaching up to 
2 mV to 3 mV. Finally, ventricular repolarization causes the T wave, which usually extends about 
300 ms after the QRS complex. 
In order to avoid waveform distortion caused by analog filters, standard diagnostic ECG 
systems require a minimal passband from 0.05 Hz to 100 Hz [36], which is designed to have a flat 
response in phase and amplitude in the whole ECG bandwidth, shown in Fig. 2.2. 
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Fig. 2.2.  Power spectrum of the ECG and its waves, adapted from [6]. 
Nevertheless, portable ambulatory devices intended to only analyze rhythm and relevant 
waveform morphology can have a narrow passband, from 0.5 Hz to 40 Hz [35], which includes 
most of the spectrum but may introduce some distortions, especially on low-frequency features 
such as the ST segment. 
The most common sources of noise in ECG recordings, identified in [6], are the EMG, power-
line interference, baseline wander, and motion artifacts. 
The EMG is due to the electrical activity of skeletal muscular cells during contraction [6] and, 
although it can be avoided in short duration tests if the patient is in resting condition, its presence is 
usually unavoidable in ambulatory scenarios. Typical amplitudes go from 0.1 mV to 1 mV and its 
spectrum goes from 5 Hz to 1 kHz, with most of the power overlapped with the QRS spectrum. 
50/60 Hz power-line interference can be present in ECG recordings from several mechanisms, 
identified in [79], although most of it can be avoided if the system is properly designed. Further, the 
interference in ambulatory ECG devices is outside the signal bandwidth and can be removed by 
filtering, although it must still be considered as it may cause saturation of intermediate stages. 
Baseline wander is due to lung volume changes during respiration, which affect the electrical 
impedance between the heart and the electrodes. As it is respiration-induced, its spectral content is 
usually between 0.15 Hz and 0.3 Hz hence it does not significantly overlap with the ECG power 
spectrum, but it must be considered to avoid amplifier saturation. 
Motion artifacts are caused by changes of the skin-electrode impedance as a result of patient 
movements or poor electrode attachment. They often occur in the band from 1 Hz to 10 Hz and 
their amplitude can be large enough to cause amplifier saturation. 
2.1.1. An overview of ECG instrumentation 
ECG leads are acquired from electrodes applied to the skin, usually with some gel to increase 
skin conductivity, avoid contact loss due to movements, and absorb surface irregularities such as 
hair. However, the use of wet-gel electrodes is not suited to measurements in ambulatory scenarios: 
Gel is embarrassing and its application is time-consuming, whereas pre-gelled electrodes must be 
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replaced after every use. Dry electrodes, where the absence of an electrolyte is rapidly compensated 
by perspiration [80], are better suited to fast measurements in ambulatory scenarios although these 
show a higher contact impedance than wet electrodes, about a few megohms at low frequencies, 
which commonly leads to a higher degree of motion artifacts and power line interference. 
The chemical reactions in the metal-electrolyte-skin interface pump electric charges between 
the electrode and the skin that result in a half-cell potential [81]. In the presence of currents, this 
half-cell potential can become unbalanced as a result of electrode impedance mismatch, which can 
be especially high in dry electrodes, and create a differential offset of several tenths of millivolt 
superposed to the ECG. Further, electrode movements change the contact impedance, which leads 
to changes in this offset recorded as motion artifacts, especially in dry electrodes due to their higher 
contact impedance. ECG analog front-ends are usually ac-coupled to reject this offset, with a 
maximal corner frequency of 0.05 Hz to avoid waveform distortion [36]. However, this cutoff 
frequency is not high enough to reject motion artifacts and imply long recovery times after 
saturation.  
Systems intended for measuring in ambulatory scenarios are allowed to have a maximal high-
pass corner frequency of 0.5 Hz [35] that provides better performance against motion artifacts and 
causes only minor distortions in low-frequency waveform features, such as the ST segment, that 
limit the diagnostic capabilities to arrhythmia monitoring and event detection. However, the phase 
response of filters with this cutoff frequency introduces systematic shifts in the QRS that should be 
considered when measuring time intervals with respect to other signals. 
The ECG is differentially amplified about 1,000 times to obtain a signal in the range of a few 
volts and afterwards it is low-pass filtered to reduce noise and 50/60 Hz power-line interference, 
which can reach amplitudes high enough to cause amplifier saturation. Four mechanisms for 
power-line interference to couple into the ECG analog front-ends identified in [79] are: variable 
magnetic fields, capacitive coupling to electrode leads, volumetric distribution effects, and 
capacitive coupling to the body, which results in common-mode and differential mode interference. 
Fig. 2.3 shows a general model to describe the coupling of some power-line interference to ECG 
systems. 
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Fig. 2.3.  Model for some power-line interference coupling to ECG acquisition systems. 
Currents induced by magnetic fields can be reduced by twisting and shortening the lead wires, 
although these are minimal in handheld devices, which are typically compact and without any 
external wires. For the same reason, currents directly coupled to the wires are small. Currents 
coupled to the electrodes can be reduced by shielding them, although the power-line coupling is 
minimal if the electrodes are covered by the body of the subject leaving no exposed areas. Another 
option is to decrease electrode impedances Zei, which in dry electrodes can only be achieved by 
increasing their area. 
The common-mode interference caused by currents coupled to the body is typically rejected by 
using a third electrode (Ze3 in Fig. 2.3) connected to the amplifier reference node, which at the same 
time is used to provide a return path for the amplifier input bias currents. Although measurements 
without a reference electrode are feasible, they are not advisable as they are more sensitive to 
electrostatic charges [82]. The common-mode interference in three-electrode systems depends on 
the current flowing through the body, which cannot be altered, and the reference electrode Ze3, 
which motivated the design of the driven-right-leg circuit (DRL) to virtually decrease the 
impedance of this electrode to zero [83] in ancient grounded ECG systems (where Ziso = 0). 
However, modern ECG systems, and especially battery-operated portable devices, are isolated 
hence the current through the third electrode is minimal and the common-mode interference is 
easily rejected by typical values of common-mode rejection ratio (CMRR). Therefore, the impact of 
this interference on the recorded signals is minimal and the use of a DRL, which implies additional 
components that increase the cost, may be unjustified. Further, the impact of the DRL on the 
volumetric distribution of currents into the body Zti is unknown and can even cause an increase of 
the overall interference. A more detailed analysis of this issue was reported in [C1]. 
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The differential interference caused by common mode currents coupled to the body is 
proportional to the common-mode voltage and the imbalance between electrode impedances Zei 
compared to the amplifier input impedance Zcm, which turns the common-mode voltage into 
differential thus reducing the effective CMRR. This interference can only be reduced by decreasing 
the impedance of the electrodes, which in dry electrodes can only be achieved by increasing their 
area, or by using an amplifier with Zcm>>Zei. 
Finally, volumetric effects, modeled by Zti, are strongly dependent on the position of the 
electrodes relative to interference sources hence cannot be predicted. The placement of two 
symmetrical ground electrodes close to the recording electrodes leads to lower levels of interference 
in grounded systems [84] but this needs more electrodes and its effectiveness in isolated systems 
has not been verified. 
The remaining ECG interference can be removed by analog filtering although the minimal low-
pass cutoff frequency to acquire the ECG without distortion set by the standard for diagnostic 
ECG devices is 100 Hz [36]. In ambulatory scenarios, where power-line interference is potentially 
higher, ECG acquisition systems are allowed to have a minimal low-pass corner frequency of 40 Hz 
[35] that allows filtering of the interference and causes only minor distortions on high-frequency 
waveform features. However, the same as in the high-pass stage, analog filters introduce systematic 
shifts in the QRS that should be characterized when measuring time intervals between the ECG 
and other signals. 
Finally, the effect of phase response can be avoided by using digital filters offline, applied in 
forward and reverse directions, which cause zero-phase response due to phase cancellation in both 
directions and an amplitude response that equals the squared amplitude response of the original 
filter. Consequently, these filters have lesser impact on timing measurements although some analog 
filtering must still be included to avoid amplifier saturation. 
2.1.2. Determination of error sources in the ECG R-wave timing 
Most of the time intervals measured from the ECG take the R wave as a reference, as it is the 
most prominent feature of the waveform and can be easily detected with the widely-used Pan-
Tompkins algorithm [85]. In handheld devices, the uncertainty of the R-wave timing is tipically 
limited by the EMG, which is present in higher levels than in clinical recordings and cannot be fully 
removed by linear filtering as its spectrum is overlapped with the QRS spectrum and constitute a 
limit for the standard uncertainty [86] in the R-wave timing. However, several parameters of the 
signal acquisition system, such as the phase response of analog filters, sampling frequency, 
interpolation and the number of bits of the ADC, can introduce significant errors to the 
measurement that must be characterized to maintain the uncertainty of the R-wave timing in the 
level set by the EMG.  
The effect of the EMG on the uncertainty of the R-wave timing has been evaluated from the 
timing shifts Δt of the R wave in a noise-free recording with different levels of added simulated 
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EMG noise [87]. Typical EMG levels in handheld ECG recordings were estimated from 14 healthy 
subjects using the system described in section 2.1.3 with the bandwidth set according to the 
standard for diagnostic ECG devices. In order to induce hemodynamic changes, the subjects were 
asked to perform a paced respiration maneuver [88] at 0.1 Hz for 50 s. The same maneuver was 
used to evaluate the performance of a multi-signal system intended for measuring several intervals 
of interest in [C3]. The signals were acquired and sent to a PC using the system described in section 
2.4.1. The EMG was measured in the isoelectric interval between T and P waves of the first 5 
heartbeats of each recording. The mean and maximum of the measured EMG root mean square 
(rms) was 17 mV and 34 mV, respectively, which correspond to 17 µV and 34 µV rms at the input. 
Several successive levels of simulated EMG were added to a 100 ms ECG recording, obtained 
from a single subject by using the standard diagnostic ECG system described in [89] with attachable 
wet-gel electrodes placed at the shoulders. The EMG was modeled by filtering additive white 
Gaussian noise (AWGN) with a first-order band-pass filter with cutoff frequencies 35 Hz and 90 
Hz, which gives a mean frequency of 90 Hz and a median frequency of 73 Hz according to the 
characterization of the signal reported in [6]. This method was developed to evaluate the 
performance of a heart rate algorithm suited to signals with high levels of EMG in [J1]. Fig. 2.4 
shows a power spectral density estimation of the simulated EMG. 
 
Fig. 2.4.  Power spectrum estimation of the simulated EMG. 
The uncertainty of the R-wave timing was estimated from the standard deviation of the timing 
shifts of the R waves on the recordings with added EMG with respect to the original recordings, 
σ(Δt). Fig. 2.5 shows the standard uncertainty of the R-wave timing for several levels of EMG in 
diagnostic and ambulatory ECG systems. 
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Fig. 2.5.  Effect of the EMG noise level on the standard uncertainty of the R-wave timing in 
diagnostic and ambulatory ECG systems. 
For a typical level of EMG below 35 mV rms, the standard uncertainty of the R-wave timing is 
about 2 ms in diagnostic ECG systems and about 1 ms in ambulatory ECG systems, where most of 
the EMG power is rejected by the 40 Hz low-pass filter. Therefore, the best option to achieve a 
minimal uncertainty in ambulatory scenarios is to use the ambulatory ECG bandwidth, since the 
EMG limits the uncertainty in the measurement, while keeping the other uncertainty sources below 
the 1 ms level. 
Analog filters are also a source of error in timing measurements since their phase response can 
change the waveform morphology and shift the detected waves. As most of this error is systematic 
it is mainly reflected on a mean time shift E(Δt) and should be estimated and corrected by 
calibration before estimating the uncertainty of the R-wave timing. 
The influence of the cutoff frequency of the ECG high-pass and low-pass filters was estimated 
from the same 14 recordings previously used to measure the EMG by using three common analog 
filters: a first order, a second order Butterworth, and a second order Bessel. The systematic shift of 
the ECG R-wave timing introduced by analog filters is shown in Fig. 2.6. 
 
Fig. 2.6.  Systematic shift of the R-wave timing introduced by analog filters. 
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The systematic shift of the R-wave timing introduced by analog high-pass filters in the 
frequency range studied is below the standard uncertainty introduced by typical EMG noise 
although the systematic shift introduced by low-pass analog filters is significantly greater. Therefore, 
measurements using the ambulatory ECG bandwidth will require calibration to achieve a minimal 
uncertainty when measuring time intervals with respect to other signals. 
Finally, the ADC is a source of uncertainty in time interval measurements as time and 
amplitude quantization cause a shift of the measured points. First, time quantization is an implicit 
limit of timing measurements although the resolution can be increased by interpolation if the limits 
set by the Nyquist theorem are respected. However, this requires additional offline processing, 
which can be limited in low-cost microprocessors, and the uncertainty of the measurement will be 
determined by the performance of the different interpolators. 
The uncertainty introduced by interpolation was estimated from the 100 s recordings 
previously used to characterize the uncertainty introduced by the EMG (Fig. 2.5). The signal was 
down-sampled at several factors and then interpolated to the original frequency by using two 
common interpolators: linear and spline. The standard uncertainty was calculated from the R-wave 
timing differences between the original and the interpolated recordings. Fig. 2.7 shows the standard 
uncertainty of the R-wave timing introduced by interpolation.  
 
Fig. 2.7.  Standard uncertainty of the R-wave timing introduced by interpolation. 
In order to achieve an uncertainty in the R-wave timing below the level of 1 ms set by the 
EMG noise, the sampling frequency can be reduced up to 333 Hz with linear interpolation and up 
to 125 Hz with a spline interpolation. 
Waveform distortions caused by amplitude quantization that can also shift the detected waves. 
The effect of amplitude quantization was evaluated from the previous recording by decreasing the 
number of quantization levels. After that, the recordings were band-pass filtered with a first-order 
filter with cutoff frequencies 0.05 Hz and 100 Hz applied forward and reverse and the standard 
uncertainty was calculated from the R-wave timing differences between these and the original 
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recording. Fig. 2.8 shows the standard uncertainty of the R-wave timing with respect to the 
resolution of the ADC.  
 
Fig. 2.8.  Standard uncertainty of the R-wave timing with respect to the ADC resolution. 
A minimal resolution of 4 bits in the ADC is required in order to achieve a standard uncertainty 
of the R-wave timing below the level of 1 ms set by the EMG noise. 
2.1.3. ECG analog front-end design 
In addition to the requirements established for a minimal uncertainty in the measurement of 
the R-wave timing in section 2.1.2, the ECG analog front-end has been designed to operate in 
ambulatory scenarios while having a minimal number of active components, which results in a 
lower cost and lower power consumption. The gain and bandwidth was set according to the 
standard for ambulatory ECG acquisition systems [35], which reject more EMG than diagnostic 
ECG systems (see Fig. 2.5), and the maximal output noise was set below typical EMG levels (30 
mV). The resolution of the ADC was set to 8 bits to match the capabilities of common cost-
effective signal acquisition systems, and the sampling frequency was set to 1 kHz, which introduces 
an uncertainty in the R-wave timing below the level set by the EMG (1 ms) without requiring 
interpolation.  
The design specifications for the ECG analog front-end are summarized in Table 2.1. 
Table 2.1.  ECG analog front-end specifications. 
Parameter Value 
Gain 1,000 
Bandwidth 0.5-40 Hz (ambulatory ECG) 
Maximal rms output noise 30 mV 
Resolution 8 bits 
Sampling frequency 1 kHz 
Additional considerations Compatible with dry electrodes. 
Compatible with an IPG system, which can  
add up to 1.5 V at 20 kHz. 
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Although four-electrode dual-ground systems have better performance against volumetric 
effects of currents coupled to the body, the simultaneous measurement of an IPG requires isolation 
between system references, which is unpractical since dual grounds interfere with the current 
injection system. Further, two-electrode systems do not easily drain electrostatic charges hence 
three-electrode systems perform better.  
Dry electrodes contacted by fingers are a practical design that works with different hand 
morphologies and is suitable for fast short-term measurements. A common option is to connect 
the dry electrodes to a capacitor in series with each sensing electrode and in parallel with a resistor 
to block differential voltages caused by mismatches in skin polarization that can saturate the 
instrumentation amplifier [90]. However, in order to assure an optimal performance these systems 
require input resistors of several hundreds of megohms, which can cause amplifier saturation due to 
bias currents, hence the only solution is to directly connect the dry electrodes to a high-impedance 
amplifier input. 
Although dry electrodes can be directly connected to the instrumentation amplifier, this 
configuration does not reject input offsets or the IPG, which would drastically limit the maximal 
gain of the instrumentation amplifier and require an additional amplification stage. An alternative 
solution is to connect the dry electrodes to voltage followers and use a fully-differential band-pass 
filter to couple them to the instrumentation amplifier. This configuration provides a high-
impedance input for the dry electrodes, rejects the offset caused by skin polarization and input bias 
currents, and at the same time reduces interference and motion artifacts to prevent amplifier 
saturation. The filter used for that purpose, shown in Fig. 2.9, is a novel design evolved from the 
topology proposed in [89], designed to allow the flow of bias currents without using any grounded 
component. 
 
Fig. 2.9.  Fully-differential band-pass filter. 
The corner frequencies of the band-pass filter shown in Fig. 2.9 are 
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and the gain is 
  
  
     
  
(2.3) 
By choosing R3 >>R2, the gain is about 1, although at frequencies above fh the input impedance 
is low due to its dependency on R2. However, the use of buffered inputs makes this feature 
irrelevant. The corner frequencies of the filter were set to 0.5 Hz and 40 Hz. 
The ECG requires a gain about 1,000 but the instrumentation amplifier should not saturate 
because of the IPG. At 20 kHz, the band-pass filter provides -54 dB attenuation and any amplifier 
with a gain-bandwidth product below 5 MHz, which is common in instrumentation amplifiers, 
would introduce an additional -12 dB (-6 dB/octave) hence 1.5 V, 20 kHz at the input would result 
in a ripple of approximately 0.75 V at the output of the instrumentation amplifier, which is low 
enough to avoid amplifier saturation. 
Finally, in order to reject the remaining IPG signal and power-line interference, an additional 
first order low-pass filter with cutoff frequency set to 40 Hz was placed at the output of the 
amplifier. The equivalent output impedance of the filter is small enough as compared to the input 
impedance of the following stage. 
Fig. 2.10 shows the full analog front-end designed for ECG acquisition.  
 
Fig. 2.10.  Designed ECG analog front-end. 
2.1.4. ECG analog front-end characterization 
The designed ECG analog front-end was characterized and evaluated according to the current 
standards for ECG acquisition systems. Fig. 2.11 shows the measured gain and phase response of 
the ECG analog front-end in the range from 0.05 Hz to 1 kHz. 
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Fig. 2.11.  Measured gain and phase response of the ECG analog front-end. 
The measured gain at the output of the instrumentation amplifier at 20 kHz was about -4 dB, 
which is enough to ensure compatibility with the IPG system described in section 2.2.3. The 
measured CMRR at 50 Hz was 106 dB, which is enough to reject typical values of common-mode 
interference from power lines in portable battery-operated devices. The rms noise at the output was 
1.8 mV, which is much lower than typical EMG noise levels. 
In order to estimate the uncertainty introduced by the analog front-end on the R-wave timing, 
two simultaneous 100 s ECG samples were obtained from a single subject by using the designed 
system and the standard ECG amplifier for diagnostic described in [89] with pre-gelled electrodes 
placed at the shoulders. Fig. 2.12 shows a sample of the measured recordings. 
 
Fig. 2.12.  Simultaneous ECG samples from the designed system (top) and a standard diagnostic 
ECG system [89] (bottom). 
Compared to the standard diagnosis ECG, the signal from the designed system shows more 
artifacts and EMG noise although the main features are still clearly identifiable for diagnosing 
arrhythmias. The time positions of the R-wave were measured with a modified Pan-Tompkins 
algorithm and the uncertainty introduced by the designed system was calculated as the difference 
with respect to the standard system. The mean of the timing shifts was 7.6 ms and the standard 
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uncertainty was 1.1 ms, which is coherent with the shifts introduced by filters shown in Fig. 2.6 and 
the uncertainty introduced by EMG noise shown in Fig. 2.4 respectively. 
Fig. 2.13 shows the aggregated 122 pairs of RR intervals measured from the standard ECG 
system, RRstandard, and the designed ECG system, RRhandheld, obtained from the subject during the 
experiment. 
 
Fig. 2.13.  RRhandheld vs. RRstandard, and Bland-Altman analysis of RRhandheld vs. RRstandard during paced 
respiration. 
The agreement between RR intervals in the correlation analysis is high, and the uncertainty of 
the RRhandheld is coherent with the reported uncertainty of the R-wave timing using the designed 
ECG system (1.1 ms) and the general equation for the uncertainty of a time difference 
 (   )  √  ( )    ( ), (2.4) 
and is about 35 times larger than the standard deviation of the RR interval during heart rate 
variability analyses (50 ms) [91]. 
2.2. The impedance plethysmogram (IPG) 
The term IPG was first introduced in the 1950s as a tool for the assessment of blood flow in 
limbs from changes in blood perfusion [7], although similar techniques had been published under 
different names since the 1930s. The IPG is the recording of impedance changes on a body 
segment caused by volume changes related to the pressure-pulse propagation through elastic 
arteries. For an arterial segment of fixed length l, cross-section A, and resistivity ρ, the basal 
resistance R is determined by  
   
 
 
  
(2.5) 
Assuming an increase of volume only in the radial axis, the increase of resistance ΔR is related to 
the increase of cross-sectional area ΔA according to 
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IPG waveforms have the same characteristic features observed in other pressure-pulse 
waveforms such as the PPG or the PPT. Fig. 2.14 shows a representation of an IPG waveform and 
the main waves that can be identified in it [92]. 
 
Fig. 2.14.  Representation of the IPG waveform and its waves. 
IPG waveforms start with the percussion wave, caused by cardiac ejection during systole. After 
that, there is a second peak named tidal wave that results from the overlapping between the 
percussion wave and its reflections in arterial branches, mainly at the end of the aorta. The tidal 
wave amplitude depends on the PTT to the reflection site hence stiffer arteries show higher tidal 
waves compared to elastic ones [93] whereas distal sites show higher tidal waves than proximal 
sites. Subsequently, the closure of the aortic valve causes the dicrotic notch, immediately followed 
by the dicrotic wave caused by reflections of the pressure pulse at distal sites. 
Pressure-pulse signals reflect mostly respiration-related changes of venous blood volume in the 
band from 0.1 Hz to 0.4 Hz and cardiac-related changes of arterial blood volume in the band from 
0.8 Hz to 2.5 Hz [94]. However, it is commonly accepted that systems intended for the 
measurement of pressure-pulse signals must be able to record from the 1st to the 10th harmonic, 
which typically fall within the band from 0.5 Hz to 20 Hz [95], although the maximal high-pass 
corner frequency to avoid waveform distortion in the PPG is 0.2 Hz [96]. Some bandwidths 
reported for IPG devices are 0.5-10 Hz [13], 0.8-4.4 Hz [52][55] and 0.87-12.5 Hz [57].  
Motion artifacts, caused by changes in electrode impedance due to movements, are the most 
relevant source of noise in IPG recordings and typically occur in the band from 1 Hz to 10 Hz. 
Further, IPG recordings suffer from higher levels of pink noise than other pressure-pulse 
signals such as the PPG due to the higher gains that are required for its measurement. 
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2.2.1. An overview of IPG instrumentation 
The IPG is measured at relatively high frequencies, in the range from 1 kHz to 100 kHz, to 
reduce the influence of basal impedance of tissues and electrodes, and to assure safety conditions 
for the patient [97]. The IPG can be obtained with only two electrodes, simultaneously used to 
inject current and measure the voltage drop, but this method also measures electrode impedances 
that can change due to movements and introduce motion artifacts [98]. Further, two-electrode 
systems are more sensitive to changes in the areas close to the electrodes than in other areas along 
the current path due to current constriction near the electrodes [99]. 
Most IPG systems use four electrodes to separate injection form measurement and to exclude 
the impedance of injection electrodes from the measurement. However, motion artifacts can still 
affect recordings due to changes in the contact impedance of the measurement electrodes, which 
change the offsets caused by input bias currents [98], or due to changes in impedance of the 
injection electrodes in low-CMRR systems [100]. 
Typical basal impedances measured at these frequencies are in the range of a few hundreds of 
ohms hence the currents injected are usually from 0.5 mA to 2 mA in order to get a drop in voltage 
of a few volts. The differential signal from the measurement electrodes is usually converted to 
single-ended by using an ac-coupled instrumentation amplifier that rejects electrode drift, low 
frequency noise and power-line interference, with typical gains between 1 and 100. Afterwards, the 
signal is downshifted to baseband by synchronous sampling [13], rectification with diodes and low-
pass filtering [98], or synchronous demodulation with a switched-gain amplifier and low-pass 
filtering [60].  
Once in the baseband, the signal still requires filtering the dc component, which belongs to the 
basal impedance, and amplification of the pulsatile signal from 10 to 1,000 times. Some systems 
include a low-pass filter to provide additional high-frequency noise rejection at this point.  
2.2.2. Determination of error sources in the IPG pressure-pulse timing 
The IPG pressure-pulse timing is typically measured from the foot of the wave, as this feature 
is less affected by waveform changes due to pulse propagation and by the overlap of reflected 
waves, with the intersecting tangents method due to its superior performance [32]. Unlike the ECG, 
which is measured in the base band, the IPG modulates a high-frequency carrier hence the signal 
acquired is narrowband and the EMG has little effect on it. However, the uncertainty in the 
pressure-pulse timing is still limited by motion artifacts, which can be avoided with a proper 
measurement setup and data acquisition system. As a result of the low gain of the instrumentation 
amplifier stage and the high total gain of the system, IPG recordings usually show higher levels of 
pink noise than other pressure-pulse signals such as the PPG that constitute a limit for the 
uncertainty in the pressure-pulse timing. However, unlike the EMG in ECG recordings, the pink 
noise level can be reduced by proper instrumentation design. For the measurement of time intervals 
between both signals, an acceptable level of uncertainty due to pink noise in the IPG would be the 
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same than the uncertainty introduced by the EMG calculated in section 2.1.2, i.e., 1 ms. As with the 
ECG R-wave timing, several parameters of the signal acquisition system, such as the phase 
response of analog filters, sampling frequency, interpolation, and the number of bits of the ADC, 
can introduce significant errors to the measurement that must be characterized to maintain the 
uncertainty below the 1 ms level.  
The effect of pink noise on the uncertainty of the pressure-pulse timing has been evaluated 
from the timing shifts in a noise-free recording with different levels of added simulated pink noise 
[87]. Several successive levels of pink noise were added to a 100 ms PPG recording obtained from a 
single subject with the system described in section 2.4.2 simulating a noise-free IPG recording. The 
uncertainty of the pressure-pulse timing was estimated from the standard deviation of the timing 
shifts of the foot of the pressure pulse on the recordings with added pink noise with respect to the 
original recordings, σ(Δt). Fig. 2.15 shows the effect of pink noise on the standard uncertainty of the 
pressure-pulse timing. 
 
Fig. 2.15.  Effect of the pink noise level on the standard uncertainty of the pressure-pulse timing. 
The maximal pink noise rms to assure for the foot of the pressure pulse an uncertainty of 1 ms 
similar to that of the ECG R-wave timing calculated in section 2.1.2 is 10 mV. 
As described for the ECG in section 2.1.2, another source of uncertainty in IPG recordings is 
the phase response of analog filters, which can introduce systematic shifts on the pressure-pulse 
timing. The influence of the cutoff frequency of the IPG high-pass and low-pass filters was 
estimated from 14 healthy subjects using the system described in section 2.2.3. In order to induce 
hemodynamic changes, the subjects were asked to perform a paced respiration maneuver at 0.1 Hz 
for 50 s. The signals were acquired and sent to a PC using the system described in section 2.4.1. 
Several cutoff frequencies in the range of interest where simulated by using three common analog 
filters: first order, second order Butterworth, and second order Bessel. The systematic shift 
introduced in the pressure-pulse timing introduced by the simulated analog filters is shown in Fig. 
2.16. 
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Fig. 2.16.  Systematic shift of the IPG pressure-pulse timing introduced by analog filters. 
The systematic shift on the pressure-pulse timing introduced by analog high-pass and low-pass 
filters is several times greater than the standard uncertainty of 1 ms previously reported for the 
ECG R-wave timing in section 2.1.2 hence absolute timing measurements between the IPG and 
other signals should be calibrated in order to achieve minimal uncertainty. 
The previously described uncertainty introduced by the ADC also affects the timing of the IPG 
pressure-pulse. The effect of interpolation was estimated from the 100 s recording previously used 
to characterize the uncertainty introduced by pink noise. The signal was down-sampled at several 
factors and then interpolated to the original frequency by using two common interpolators: linear 
and spline. The standard uncertainty was calculated from the pressure-pulse timing differences 
between the foot of the original pressure pulse and that of the interpolated recording. Fig. 2.17 
shows the standard uncertainty of the IPG pressure-pulse timing introduced by interpolation. 
 
Fig. 2.17.  Standard uncertainty of the IPG pressure-pulse timing introduced by interpolation. 
The sampling frequency can be reduced up to 50 Hz without introducing an uncertainty in the 
pressure-pulse timing above the standard uncertainty of 1 ms previously reported for the ECG R-
wave timing in section 2.1.2 by using any of the two interpolation methods studied. 
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The effect of amplitude quantization was evaluated from the previous recording by decreasing 
the number of quantization levels. After that, the recording was band-pass filtered with a first-order 
filter with cutoff frequencies 0.2 Hz and 20 Hz applied forward and reverse and the standard 
uncertainty was calculated from the differences between the foot of the pressure-pulse and that of 
the original recording. Fig. 2.18 shows the standard uncertainty as a function of the resolution of 
the ADC.  
 
Fig. 2.18.  Standard uncertainty of the IPG pressure-pulse timing with respect to the ADC resolution. 
A minimum of 7 bits in the ADC are required in order to achieve a standard uncertainty below 
the standard uncertainty of 1 ms previously reported for the ECG R-wave timing in section 2.1.2. 
2.2.3. IPG analog front-end design 
As in the ECG case, the IPG analog front-end has been designed to operate in ambulatory 
scenarios while having a minimal number of active components, which results in a lower cost and 
lower power consumption, in addition to the requirements for a minimal uncertainty in the 
measurement of the pressure-pulse timing established in section 2.2.2. The current and gain were 
set according to common values in IPG systems, and the bandwidth was set according to [95] and 
[96]. The maximal output noise was set according to the results in Fig. 2.15 whereas the resolution 
of the ADC was set to 8 bits to match the capabilities of common cost-effective acquisition 
systems, and the sampling frequency was set to 1 kHz, which introduces an uncertainty in the 
pressure-pulse timing below 1 ms without requiring interpolation. 
The design specifications for the IPG analog front-end are summarized in Table 2.2. 
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Table 2.2.  IPG analog front-end specifications. 
Parameter Value 
Frequency 20 kHz 
Current 0.5 mAp 
Gain 2200 
Bandwidth 0.2-20 Hz [95][96] 
Maximal rms output noise 10 mV 
Resolution 8 bits 
Sampling frequency 1 kHz 
Additional considerations Compatible with dry electrodes. 
 
The IPG measurement frequency was 20 kHz, which is a good tradeoff between interference 
with baseband signals, such as the ECG, and performance yet does not need costly components. 
The current source was built from a 20 kHz oscillator connected to a Howland current source 
designed to inject 0.5 mA peak current, which is suited to typical impedances measured including 
those of the electrodes. 
At this frequency it is not necessary to connect the dry electrodes to voltage buffers to assure 
an optimal performance as the electrode impedance is only a few kilohms. Instead of using a 
capacitor in series with the gain-setting resistor [100], which requires a large gain for optimal 
performance, the measurement electrodes were ac-coupled to the amplifier to reject electrode 
drifts, low-frequency noise, and power line interference by using the fully-differential high-pass 
filter described in [89]. The resistors were selected large enough to achieve an input impedance 
about 100 times larger than electrode impedances [100]. Basal impedances limit the maximal gain of 
this stage, which was set to 50. 
The signal was downshifted to the baseband with a coherent demodulator based on a switched-
gain amplifier [60], as synchronous sampling requires a more complex setup and diode-based 
rectification has worse SNR. Further, coherent demodulators are especially suited to low-noise 
designs as they keep the pink noise of previous stages outside the band of interest. An integrator 
was added in a feedback loop from the output to the reference terminal of the instrumentation 
amplifier to reject the offset at the output of the switched gain amplifier caused by basal 
impedances thus allowing maximal gain on the next stages. This setup performs like a high-pass 
filter [89] with corner frequency set to 0.15 Hz and also increases the performance of the signal that 
drives the switch, which is highly sensitive to offsets. 
Finally, the output from the demodulator was filtered and amplified to remove high-frequency 
components with a second-order Sallen-Key filter with gain set to 220 and a cutoff frequency of 
20 Hz. This configuration was enough to reject the 20 kHz carrier and the power-line interference. 
Fig. 2.19 shows the full analog front-end designed for IPG acquisition. 
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Fig. 2.19.  Designed IPG analog front-end. 
2.2.4. IPG analog front-end characterization: IPG to PPG comparison 
Since IPG acquisition systems are not standardized, the designed system has been characterized 
and evaluated in comparison to a commercial PPG sensor, which is the most used technology to 
record pressure-pulse waveforms in research and clinical settings [5]. Even though both signals are 
sensitive to plethysmographic changes, other factors such as the blood flow, orientation of the 
erythrocytes, and the contact pressure of the PPG sensor have influence on the measured 
waveform and must be characterized in order to grant an adequate performance of the IPG in 
measurements typically performed with the PPG. 
The uncertainty in the pressure-pulse timing introduced by the noise of the IPG system was 
estimated from a 100 s recording with the injection and detection electrodes connected to a 100 Ω 
resistor, simulating typical basal impedances of local IPG measurements. The rms value of the 
measured signal, completely attributed to pink noise, was 9 mV, which means that the standard 
uncertainty introduced on the pressure-pulse timings by the system noise according to the results 
shown in Fig. 2.15 is about 1 ms. 
The performance of the IPG as a surrogate of the PPG was evaluated by simultaneously 
measuring the PAT from the ECG R-wave to the two signals obtained at the finger. The ECG was 
obtained from the standard ECG system described in [89] connected to attachable wet-gel 
electrodes placed in the shoulders. The IPG and the PPG were obtained from the system described 
in section 2.2.3 and the system described in section 2.4.2, respectively. The IPG injection electrodes 
were placed in the distal and proximal phalanxes whereas the measurement electrodes were placed 
at the intermediate phalanx, as close as possible to the PPG sensor placed at the distal phalanx, as 
shown in Fig. 2.20. 
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Fig. 2.20.  Setup for the IPG system characterization. 
The IPG, PPG, and the ECG were simultaneously recorded from three healthy subjects, all of 
them without any medical condition. In order to avoid the effect of motion artifacts that could 
hinder the analysis, the IPG was obtained from attachable wet-gel electrodes. In order to induce 
hemodynamic changes, the subjects were asked to perform a paced respiration maneuver at 0.1 Hz 
for 100 s. The signals were acquired and sent to a PC using the system described in section 2.4.1. 
The ECG R-wave timing was measured by applying a modified Pan-Tompkins algorithm, whereas 
pressure-pulse timings were measured by applying the tangent intersection method. Fig. 2.21 shows 
a PAT sample measured from the ECG, PPG, and the IPG representative of the measured traces. 
 
Fig. 2.21.  Example of the PAT traces from the ECG, PPG, and the IPG obtained during paced 
respiration. 
The hemodynamic changes induced by paced respiration in the three samples were in phase 
and had similar amplitudes. The correlation coefficients between the PAT measured from the PPG 
and from the IPG for each subject were 0.99, 0.99, and 0.94 respectively. 
The uncertainty introduced by the IPG was calculated as the difference in PAT with respect to 
the PPG. The systematic shifts measured were -11.2 ms, -9.3 ms, and -13.4 ms, which are too large 
to be attributed to the distance between sensors or mismatches in the cutoff frequency of analog 
filters. Further, these differences cannot be attributed to different sensitivities of the IPG and the 
PPG to volume and flow, as both magnitudes are in phase at the upstroke. 
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The standard uncertainties measured were 2.9 ms, 2.0 ms, and 3.3 ms, which are higher than 
the maximal uncertainty introduced by the system noise at the output and represent about 1.5 % of 
the total PAT and 10 % of the respiratory-induced variations in PAT. 
Fig. 2.22 shows the aggregated 407 pairs of PAT values measured from the ECG R wave to the 
PPG pressure pulse, PATPPG, and to the IPG pressure pulse, PATIPG, obtained from the 3 subjects 
during the experiments. 
 
Fig. 2.22.  PATIPG vs. PATPPG, and Bland-Altman analysis of PATIPG vs. PATPPG during paced 
respiration. 
The agreement between PAT values in the aggregated analysis is good, although the mean and 
standard deviation of the difference is slightly larger with respect to the values reported for 
individual subjects. 
The reasons for this higher uncertainty compared to the expected uncertainty introduced by the 
system noise can be better explained by examining the uncertainty traces. Fig. 2.23 shows an 
example of the uncertainty of the PAT measured from the IPG as a surrogate of the PPG, obtained 
from the same subject of Fig. 2.21.  
 
Fig. 2.23.  Example of the uncertainty of the PAT measured from the IPG as a surrogate of the PPG. 
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The uncertainty of the pressure-pulse timing shows a component synchronous with the 
respiration-induced changes in PAT, with a maximal delay coincident with the shortest PAT, and a 
low-power random component attributable to noise and artifacts. A plausible explanation of this 
effect is the influence of the PPG sensor contact pressure, which is known to cause changes in the 
amplitude and morphology of the measured waveforms [11], and cause time shifts on the measured 
features [12]. 
Two additional recordings were obtained from the subjects of Fig. 2.21 and Fig. 2.23, with the 
PPG sensor set intentionally looser in the first recording and tighter in the second. The mean 
uncertainties measured were -2.1 ms and -36.3 ms respectively. Fig. 2.24 shows an example of the 
waveforms recorded with normal, high, and low contact pressure with the difference between 
maxima and minima of the waveforms. 
 
Fig. 2.24.  Example of the PPG and IPG waves measured with normal (a), low (b), and high (c) 
sensor contact pressure and the difference between their maxima and minima. 
By comparison with the IPG, an increase of contact pressure causes a decrease of amplitude of 
the dicrotic notch and a delay of the upstroke in the PPG. The recording with low contact pressure 
shows the best agreement between IPG and PPG waveforms, although this configuration is 
extremely sensitive to motion artifacts. In the recording with high contact pressure, the IPG signal 
also seems influenced as both signals are clearly overdamped. 
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This experiment shows that the contact pressure of the PPG sensor not only affects the 
amplitude of the waveform but also the timing of the upstroke by acting like a mechanical low-pass 
filter. As the PPG sensor used in the tests is mounted on a fixed-length strap, the increase of blood 
volume induced by paced respiration causes an increase of contact pressure, which could explain 
the results shown in Fig. 2.23.  
Similar results were obtained by using other commercial systems including a transmission PPG 
system and a glued PPG system hence it can be concluded that the PPG is not a reliable source for 
absolute time interval measurements if contact pressure is not well controlled, since the uncertainty 
introduced by this phenomena is potentially higher than the uncertainty attributable to noise in the 
PPG. 
In order to separate this effect, which is intrinsic to the PPG system but not to the IPG system, 
and estimate the uncertainty introduced by the IPG system, the uncertainty traces were filtered by 
using a fourth-order Butterworth low-pass filter with cutoff frequency set to 0.2 Hz applied 
forward and reverse to estimate respiration-induced uncertainty introduced by the PPG. The 
uncertainty introduced by the IPG system was obtained from the difference between the original 
uncertainty and that estimated for the PPG. Fig. 2.25 shows the estimated contributions of the IPG 
and the PPG in the uncertainty trace in Fig. 2.23. 
 
Fig. 2.25.  Estimation of the contributions of the IPG and the PPG to the uncertainty of the PAT 
obtained from the IPG as a surrogate of the PPG shown in Fig. 2.23. 
The estimated contributions of the IPG to the uncertainty of the PAT of each subject were 
1.1 ms, 0.9 ms, and 1.8 ms respectively, which are coherent with the voltage noise measured at the 
output and the effect of pink noise predicted from Fig. 2.15. On the other hand, the estimated 
contribution of the PPG to the uncertainty of the PAT due to changes in the contact pressure 
under paced respiration was 2.6 ms, 1.9 ms, and 2.7 ms respectively, and clearly predominates over 
the uncertainty attributed to the IPG. 
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2.3. The ballistocardiogram (BCG) 
The BCG is the recording of forces caused by blood displacements through the arterial tree as 
a result of cardiac ejection. These forces can be measured from the displacement, velocity or 
acceleration of the gravity center of the body and have components in all three geometric axes. The 
first observations of the BCG were performed in 1877 [62] although the technique remained 
unpublished until some years later [63]. The practical limitations of early BCG recorders, which 
were cumbersome fully-mechanical devices, combined with the advent of the ECG and, later, 
catheters and ultrasound techniques, lead to the progressive abandonment of the technology until 
recent times, when technological advancements made possible the measurement from simple and 
cost-effective modified weighing scales [66], which are especially suited to periodic monitoring in 
ambulatory scenarios since only require the subject to stand motionless on the scale to record the 
BCG in the head-feet axis, the so-called longitudinal BCG 
The weighing-scale BCG waveform and its main waves are named using alphabetically 
consecutive letters from H to N, as shown in Fig. 2.26, 
 
Fig. 2.26.  Representation of the weighing-scale BCG waveform and its waves. 
Several studies have been carried out to relate the main BCG waves to physiological events in 
the cardiac cycle [101] [102] although most of these are referred to the ultra-low-frequency BCG 
obtained from instrumented beds [73], in which the body of the subject is weakly coupled to the 
environment and the BCG is recorded from the displacement of the body centre of gravity [8], and 
do not necessarily apply to the waves of the weighing-scale BCG due to their different nature. The 
weighing-scale BCG waveform starts with the H wave followed by the IJK complex, which is its 
most clearly identifiable feature and is generally attributed to cardiac ejection. The ensuing L, M, 
and N waves are mostly attributed to the superposition of pressure-pulse reflections in peripheral 
arteries and secondary reflections in the aorta. 
There are currently no standards for the acquisition of the BCG although it is known that the 
frequency components of the signal are mostly in the band from 1 Hz to 10 Hz [103]. In order to 
avoid possible waveform distortions due to the phase response of analog filters, early studies 
recommended a low-pass frequency of 30 Hz [104] or a minimal bandwidth of 0.5-50 Hz [105], 
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although systems intended for time interval measurements usually have narrower bandwidths, such 
as 0.1-10 Hz [66], 0.2-25 Hz [70], 0.5-30 Hz [14], and 0.1-25 Hz [106].  
Motion artifacts, in the frequency band from 1 to 10 Hz, are the most relevant noise source in 
BCG recordings, especially in recordings obtained from standing subjects. 
2.3.1. An overview of BCG instrumentation 
BCG systems built from weighing scales use their strain gauges, mounted in a Wheatstone 
bridge, to transform vertical forces into an electrical voltage. The differential signal is usually ac-
coupled to a differential amplifier to remove the dc component due to body weight, which is often 
implemented with an integrator in a feedback loop to the reference node of the instrumentation 
amplifier [107], or the same plus a differential filter [66]. Typical gains of this stage are in the range 
from 10 to 1,000. 
Afterwards, the signal is usually band-pass filtered to remove offsets caused by bias currents 
and to reduce high-frequency noise and interference. Finally, the signal is amplified by about 10 to 
100 times to obtain an output voltage in the range of a few volts. Some systems include an 
additional low-pass filter to further reject high-frequency noise. 
Alternatively, the Wheatstone bridge can be ac-driven to achieve better noise performance 
[108]. This design uses a similar structure with the only addition of a demodulation block after the 
instrumentation amplifier. 
2.3.2. Determination of error sources in the BCG J-wave timing 
Time intervals measured from the BCG usually take the J wave as a reference as it is the most 
prominent feature of the waveform. The simplest algorithms for its detection relay on a windowed 
detection of the maximum by using other reference signals such as the ECG. The uncertainty in 
these measurements is usually limited by motion artifacts, which are comparatively stronger and 
more frequent than in other biomedical signals. As motion artifacts are subject-dependent rather 
than system-dependent, typical values of uncertainty in the J-wave timing are calculated in section 
2.3.4 below. For the measurement of intervals between both signals, an acceptable level of 
uncertainty would be the same than the uncertainty introduced by the EMG calculated in section 
2.1.2 that was also proposed for the IPG pressure-pulse timing in section 2.2.2, that is, 1 ms. As 
with the ECG R-wave timing and the IPG pressure-pulse timing, several parameters of the signal 
acquisition system, such as the phase response of analog filters, sampling frequency, interpolation 
and the number of bits of the ADC, can introduce significant errors to the measurement that must 
be characterized to maintain the uncertainty below the 1 ms level. 
Unlike the ECG and the IPG, there seems to be no consensus about the minimal bandwidth 
for BCG acquisition required to analyze the influence of the phase response of analog filters. In 
order to estimate its bandwidth, the BCG has been acquired from the modification of the system 
described in section 2.3.3 shown in Fig. 2.27. 
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Fig. 2.27.  System to study the BCG bandwidth. 
This system has a relatively wide bandwidth from 0.5 Hz to 100 Hz to allow up to 50 
harmonics considering regular heart rates from 60 beats per minute to 120 beats per minute, 
although the high gain of the instrumentation amplifier causes an undesired output offset of about 
0.5 V. The BCG was recorded from 5 healthy volunteers in order to include different waveform 
morphologies in the analysis. The subjects were asked to stand motionless for 25 s to obtain 
recordings with a minimal degree of artifacts. The ECG was simultaneously recorded with the 
system described in section 2.1.3 and the signals were acquired and sent to a PC using the system 
described in section 2.4.1. Fig. 2.28 shows the mean of the BCG power spectrum estimations. 
 
Fig. 2.28.  Mean of the BCG power spectrum estimations. 
As stated in [103], 95 % of the power of the mean BCG spectrum was in the band from 0.5 Hz 
to 12.5 Hz although there was some power up to 20 Hz. In some recordings, up to 11 harmonics 
were clearly identifiable, as shown in the example in Fig. 2.29. 
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Fig. 2.29.  Example of BCG power spectrum estimation with 11 harmonics. 
Therefore, assuming that regular heart rates for standing subjects are in the range from 50 beats 
per minute to 120 beats per minute, which implies that fundamental frequencies are between 
0.8 Hz and 2 Hz, the minimal bandwidth for BCG acquisition systems to include 11 harmonics 
should be 0.5-25 Hz. 
The influence of the cutoff frequency of the BCG high-pass and low-pass filters was estimated 
from 14 healthy subjects, all of them without any medical condition, using the system described in 
section 2.3.3. In order to induce hemodynamic changes, the subjects were asked to perform a paced 
respiration maneuver at 0.1 Hz for 50 s. The signals were acquired and sent to a PC using the 
system described in section 2.4.1. Several cutoff frequencies in the range of interest where 
simulated by using three common analog filters: first order, second order Butterworth, and second 
order Bessel. The systematic shift in the J-wave timing introduced by the simulated analog filters is 
shown in Fig. 2.30. 
 
Fig. 2.30.  Systematic shift in the J-wave timing introduced by analog filters. 
The systematic shift introduced in the J-wave timing by analog high-pass and low-pass filters is 
several times larger than the standard uncertainty of 1 ms previously reported for the ECG R-wave 
timing in section 2.1.2 and the IPG pressure-pulse timing in section 2.2.4 hence absolute timing 
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measurements between the BCG and other signals should be calibrated in order to achieve minimal 
uncertainty. 
The uncertainty introduced by the ADC in timing measurements can also increase the 
uncertainty in the J-wave timing. The effect of interpolation was estimated from the five 25 s 
recordings previously used to characterize the BCG spectrum. The signal was down-sampled at 
several factors and then interpolated to the original frequency by using two common interpolators: 
linear and spline. The standard uncertainty was calculated from the J-wave timing differences 
between the original and the interpolated recording. Fig. 2.31 shows the standard uncertainty of the 
pressure-pulse timing introduced by interpolation. 
 
Fig. 2.31.  Standard uncertainty of the J-wave timing introduced by interpolation. 
In order to achieve an uncertainty lower than the standard uncertainty of 1 ms previously 
reported for the ECG R-wave timing in section 2.1.2 and the IPG pressure-pulse timing in section 
2.2.4, the sampling frequency can be reduced up to 333 Hz with linear interpolation and up to 50 
Hz with a spline interpolation. 
The effect of amplitude quantization was evaluated from the previous recordings by decreasing 
the number of quantization levels. After that, the recordings were band-pass filtered with a first-
order Butterworth filter with cutoff frequencies 0.5 Hz and 25 Hz applied forward and reverse and 
the standard uncertainty was calculated from the pressure-pulse timing differences between these 
and the original recording. Fig. 2.32 shows the standard uncertainty of the J-wave timing with 
respect to the resolution of the ADC.  
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Fig. 2.32.  Standard uncertainty of the J-wave timing with respect to the ADC resolution. 
A minimum of 4 bits in the ADC are required in order to achieve a standard uncertainty of the 
J-wave timing below the standard uncertainty of 1 ms previously reported for the ECG R-wave 
timing in section 2.1.2 and the IPG pressure-pulse timing in section 2.2.4. 
Some of the results presented on this section in were reported in [C4] and [J2] as a first step 
towards standardization of BCG systems. 
2.3.3. BCG analog front-end design 
As in the ECG and IPG case, the BCG analog front-end has been designed to operate in 
ambulatory scenarios while having a minimal number of active components, which results in a 
lower cost and lower power consumption, in addition to the requirements for a minimal uncertainty 
in the measurement of the J-wave timing established in section 2.3.2. The gain was set according to 
common values in BCG systems, and the bandwidth was set according to the results reported in 
section 2.3.2. The resolution of the ADC was set to 8 bits to match the capabilities of common 
cost-effective acquisition systems, and the sampling frequency was set to 1 kHz, which introduces 
an uncertainty in the J-wave timing below 1 ms without requiring interpolation. The maximal 
output noise has been not analyzed since motion artifacts are constant and several orders larger 
than typical levels of noise BCG recordings from standing subjects. 
The design specifications for the BCG analog front-end are summarized in Table 2.3. 
Table 2.3.  BCG analog front-end specifications. 
Parameter Value 
Gain 25,000 
Bandwidth 0.5-25 Hz (see section 2.3.2) 
Resolution 8 bits 
Sampling frequency 1 kHz 
 
The BCG is a force signal superimposed to a large offset caused by the body weight hence it 
requires high-pass filtering before amplification to avoid amplifier saturation or an ADC with a very 
large dynamic range. High-pass filtering can be achieved with a differential filter or with an 
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integrator in the feedback loop of the reference node of the instrumentation amplifier, although 
this second option is less desirable as it cannot handle large offsets and requires an additional 
amplifier. 
The high-pass filtering block has been built with the fully-differential first-order high-pass filter 
described in [89], with corner frequency set to 0.5 Hz to reject offset and some motion artifacts, 
and with resistors several times larger than the strain gauges to avoid excessive voltage loading 
effect. 
The gain of the instrumentation amplifier was set to 5,000, which causes an output offset of a 
few hundreds of millivolts due to non-ideal amplifier characteristics. In order to remove it, the final 
stage was ac-coupled to an inverter amplifier with gain 5 and corner frequency 0.5 Hz, and 
connected to a first-order low-pass filter with corner frequency set to 25 Hz to remove typical 
values of high-frequency noise and interference in BCG systems. The equivalent output impedance 
of the filter is small enough as compared to the input impedance of the following stage. 
Fig. 2.33 shows the full analog front-end designed for BCG acquisition. 
 
Fig. 2.33.  Designed BCG analog front-end. 
2.3.4. BCG analog front-end characterization 
Since BCG acquisition systems are not standardized and similar waveforms cannot be obtained 
from other reference systems, the uncertainty of the J-wave timing in BCG recordings from the 
designed system has been characterized from the high-frequency component of the RJ interval in 
the two sets of measurements described in section 2.3.2, obtained by filtering the low-frequency 
component induced by maneuvers or hemodynamic regulation. 
The first set of 5 BCG recordings, which were recorded with a low level of artifacts, were 
digitally filtered to simulate an analog band-pass filter with cutoff frequencies 0.5 Hz and 25 Hz and 
match the bandwidth of the system designed whereas the second set of 14 recordings under paced 
respiration was left unadjusted. RJ changes induced by respiration and hemodynamic regulation 
were estimated by filtering the RJ intervals with a fourth-order Butterworth low-pass filter with 
cutoff frequency set to 0.2 Hz applied forward and reverse. The uncertainty in the J-wave timing 
introduced by motion artifacts was calculated as the difference between the original RJ interval and 
the estimated maneuver-induced changes in the RJ interval. Fig. 2.34 shows an example of the 
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measured RJ and the estimation of maneuver-induced changes, extracted from the second set of 
recordings. 
 
Fig. 2.34.  Example of the total RJ interval and estimation of the maneuver-induced part during 
paced respiration. 
The mean standard uncertainty in the first set with a low degree of motion artifacts was 1.7 ms 
and the maximum was 3.1 ms, whereas in the second set with a higher level of motion artifacts due 
to the paced respiration maneuver the mean standard uncertainty was 10.4 ms and the maximum 
was 17.6 ms. The values in the second set are about 10 times greater than the uncertainty of 1 ms 
previously reported for the ECG R-wave timing in section 2.1.4 or the IPG pressure-pulse timing 
in section 2.2.4, and constitute a challenge for the measurement of the RJ interval as they are of the 
same order of the maneuver-induced changes. 
Additionally, the RJ interval was calculated from the R wave of the ECG and the J wave of an 
ensemble average composed from several consecutive BCG heartbeats, including an equal number 
between previous and consecutive. This technique, which is widely used to analyze evoked 
potentials in electroencephalography (EEG), can be applied to the BCG [106][109] to reduce 
random effects by 1/N, N being the number of samples of the ensemble average, while keeping the 
power of the signal of interest. The main advantage of this technique is that it provides low-noise 
waveforms for feature-extraction algorithms that otherwise would fail. Fig. 2.35 shows the mean 
standard uncertainty of the RJ interval obtained from the second set of recordings measured with 
this alternative method, for different number of heartbeats of the ensemble average. 
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Fig. 2.35.  Standard uncertainty of the RJ interval for different sizes of the ensemble average. 
The increase of the number of heartbeats in the ensemble average causes a decrease of the 
standard uncertainty due to artifact filtering and an increase of the standard uncertainty due to the 
misalignment of the BCG samples with respect to the ECG, which causes a filtering of the high-
frequency features of the BCG waveform. The minimal standard uncertainty achieved is 6.9 ms and 
corresponds to an ensemble average of 3 heartbeats. Fig. 2.36 shows the same RJ trace of Fig. 2.34 
calculated from a 3-heartbeat ensemble average. 
 
Fig. 2.36.  Example of the total RJ interval measured from a 3-heartbeat ensemble average and 
estimation of the maneuver-induced part during paced respiration. 
The agreement between the RJ interval and the estimated maneuver-induced changes in the RJ 
is much greater by using a 3-heartbeat ensemble average, although a higher number of intervals 
could be used to achieve lower standard uncertainties in RJ traces with slower variations. Further, 
sample misalignments as a result of RJ interval fluctuations that cause a smoothening of the BCG 
waveform can be corrected by using a realignment algorithm such as the one proposed by Woody 
for evoked potentials in EEG [110]. This method was used to reduce the level of artifacts in the 
BCG, and EMG noise in the ECG obtained from the feet in [C2]. 
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2.4. Data acquisition system and additional reference systems 
This section describes the data acquisition system and other additional systems that have been 
used to obtain additional reference physiological signals throughout the experiments. 
2.4.1. Data acquisition system 
The signals were acquired with a 10-channel 14-bit DAQ (μDAQ USB-26/30-BNC, Eagle 
Technology, Auckland, New Zealand) with input range set to ±5V and sampling frequency set to 
1 kHz, so that the sampling interval (1 ms) was somewhat below typical standard uncertainties of 
timing measurements found in preliminary tests.  
The DAQ was controlled from a custom LabVIEW® interface and the recorded signals were 
processed offline with Matlab®. 
2.4.2. Photoplethysmogram (PPG) 
The PPG system was designed from a commercial reflective PPG sensor (model 1020, UFI, 
Morro Bay, California). The sensor output was ac-coupled (0.1 Hz cutoff frequency) to a non-
inverting amplifier with gain 51, as shown in Fig. 2.37. 
 
Fig. 2.37.  Analog front-end for the PPG sensor. 
The high-frequency response of the sensor, not specified by its manufacturer, was found by 
characterizing the amplitude and phase response of the system. The result was manually adjusted to 
a simulated system with variable cutoff frequencies to found the best fit. Fig. 2.38 shows the 
measured and simulated amplitude and phase response. 
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Fig. 2.38.  Measured (markers) and simulated (lines) amplitude and phase response of the PPG 
system used. 
The best fit to the measured amplitude and phase response of the PPG was a system with a 
first-order high-pass filter with cutoff frequency 0.11 Hz, a first-order low-pass filter with cutoff 
frequency 18 Hz, and a first-order low-pass filter with a cutoff frequency of 110 Hz. 
2.4.3. Pressure pulse transducer (PPT) 
The PPT system was designed from a commercial piezoelectric sensor (model 1010, UFI, 
Morro Bay, California). The sensor was conditioned with the circuit proposed by its manufacturer, 
with an additional amplification stage with gain 10, as shown in Fig. 2.39. 
 
Fig. 2.39.  Analog front-end for the pressure pulse transducer (PPT). 
The high-pass and low-pass cutoff frequencies of the PPT system were experimentally 
determined from the discharge times of the sensor and the circuit respectively, and the values 
obtained were 0.15 Hz and 22 Hz. 
The uncertainty of the pressure-pulse timing from this PPT system was estimated by using the 
PPG as a reference from a single healthy subject, which was asked to perform a paced respiration 
maneuver at 0.1 Hz for 100 s. The PPT and the PPG were simultaneously obtained from the left 
hand index and middle fingers respectively using the PPT and the PPG system described in section 
2.4.2. The signals were acquired and sent to a PC using the system described in section 2.4.1 and 
the timing of the pressure-pulse was determined with the tangent intersection method. 
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The systematic shift of the foot of the pressure-pulse was 3.2 ms, which was expected from the 
bandwidth mismatch, and the standard uncertainty was 1.5 ms, which can be attributed to noise 
and artifacts. 
2.5. Summary 
This chapter has been devoted to the analysis of the uncertainty in time interval measurements 
from the ECG, IPG, and the BCG. First, the main sources of error in the timing of the most 
widely-measured fiducial points for each signal have been analyzed and the results show that 
standard uncertainties below 1 ms are hard to achieve in ambulatory scenarios, mostly because of 
EMG noise for the ECG, the pink noise for the IPG, and motion artifacts for the BCG, but this is 
still far below current uncertainties in several time interval measurements [29][30][31][32] that are of 
the order of tens of milliseconds.  
Afterwards, we have characterized the effect of several parameters of data acquisition systems 
to establish the minimal design requirements to assure that the uncertainties they introduce are 
below that level. Table 2.4 shows a summary of the minimal specifications required for ECG, IPG, 
and BCG acquisition systems. 
Table 2.4.  Summary of specifications for ECG, IPG, and BCG acquisition systems intended for time 
interval measurements. 
Parameter ECG IPG BCG 
Bandwidth (Hz) 0.5-40 0.2-20 0.5-25 
rms output noise (mV) 30 10 - 
Resolution (bits) 4 7 4 
Sampling frequency (linear interpolation)(Hz) 333 50 333 
Sampling frequency (spline interpolation)(Hz) 125 50 50 
 
We have found that analog filters at these frequency bands introduce significant shifts that 
must be calibrated in absolute time measurements. On the other hand, the requirements for ADC 
are not especially demanding hence costly high-performance systems are not required to achieve 
uncertainties below 1 ms. 
After the state of the art of the instrumentation circuits to process those signals has been 
reviewed, we have designed a data acquisition system tailored to each signal according to the 
specifications previously developed and oriented to measurements in ambulatory scenarios, which 
demand cost-effective low-power designs. 
For the ECG, we have designed a system compatible with an IPG system based on a novel 
passive first-order fully-differential band-pass filter that requires a minimal number of amplifiers, 
hence has lower cost and power consumption.  
The IPG characterization revealed that the uncertainty in timing measurements for the widely-
used PPG strongly depends on contact pressure, which induces higher uncertainty in timing 
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measurements than that due to pink noise in the IPG. Therefore, the IPG can be a better tool for 
the assessment of the pressure-pulse timing in spite of the popularity of the PPG.  
After analyzing some BCG traces during paced respiration, we have found that motion artifacts 
are almost 10 times larger than the minimal uncertainties achieved in other timing measurements 
from the ECG and the IPG, and become an important drawback. We have characterized a method 
based on sample averaging that reduces that uncertainty in the BCG J-wave timing at the cost of its 
ability to reflect beat-to-beat changes. 
The results described in this chapter are a necessary step towards standardization of systems 
intended for timing measurements, as several common timing measurements are currently being 
performed with systems unintended for that purpose whose impact on the measurement 
performance is unknown.  
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Chapter 3  
The IPG from limb to limb 
HE IPG obtained from limb to limb is better suited to measurements in ambulatory scenarios 
than local IPG measurements as the placement of two electrodes on each limb is easier than 
placing four electrodes on a single limb. In addition, IPG systems are obtained from electrodes that 
can be shared with systems that obtain additional signals such as the ECG, and can be easily 
integrated on the surface of daily-use objects. However, there is no model able to describe the 
response of the limb-to-limb IPG to different hemodynamic changes and therefore its usefulness is 
currently limited to obtaining the heart rate although the signal is sensitive to changes along the 
whole current path and can potentially reflect hemodynamic changes in proximal sites 
complementary to those commonly obtained from distal sites. This chapter proposes and evaluates 
a model for hand-to-hand and foot-to-foot IPG signals based on the geometry of the arterial tree. 
This novel model is built from anatomical data collected from living subjects reported in the 
literature and predicts the sensitivity of the different body segments along the current path to 
pressure changes and the effect of that sensitivity on the timing of the pressure pulse. Afterwards, 
the performance of the PAT measured from the ECG to the hand-to-hand IPG and to the foot-to-
foot IPG is evaluated in a small group of subjects. 
3.1. The potential of limb-to-limb IPG measurements 
In addition to local measurements with electrodes clustered in a small area of interest, the IPG 
can be obtained by measuring between distant sites, which yields information about the aggregated 
plethysmographic changes along the current path. The ICG is probably the most common of these 
measurements and is routinely used in research and clinical care to gain information about 
T 
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volumetric changes in the aorta [49] by measuring impedance changes between the neck and the 
abdomen. 
Impedance measurements based on electrodes placed on wrists and ankles, the so-called whole-
body impedance measurement [58], are assumed to have performance similar to that of the ICG in 
spite that it includes the impedance of the limbs. However, the reported systematic overestimation 
of PWV when using the whole-body waveform as a proximal signal suggests that the upstroke of 
the waveform is delayed with respect to the ICG upstroke and causes an underestimation of PTT. 
This delay can be attributed to the influence of distal impedance changes that also contribute to 
other whole-body impedance measurements [59]. 
Even though whole-body impedance measurements fit the criteria identified for noninvasive 
measurement of cardiovascular parameters, other impedance measurements from limbs can be 
easily integrated in common daily-use devices to yield information of interest. The IPG measured 
from foot to foot has been proposed to detect heart rate [13][60] or to increase the reliability in 
heartbeat detection combined with other signals [15], and can be obtained from the electrodes of 
modern weighing scales intended for body composition analysis. Even though the physiological 
basis of the foot-to-foot IPG has been not reported, this signal could be sensitive to the arrival of 
the pressure-pulse to the abdomen as the current flows through it from leg to leg, and the abdomen 
is currently one of the two reference measurement sites specified by the gold standard 
measurement of arterial stiffness [17]. Analogously, the measurement of impedance from hand to 
hand [61] could be sensitive to volume changes in the arteries of the thorax that reflect the earliest 
volume changes caused by cardiac ejection, the same as with the whole-body impedance 
measurement.  
These two IPG measurements between limbs are of great interest as they can potentially deliver 
information about the pressure-pulse arrival to proximal sites complementary to the information 
from other signals typically obtained at the hands such as the ECG or local pressure-pulse 
waveforms. This makes it interesting to elaborate a model able to predict the contributions of the 
different body segments along the current path to the waveform obtained and could corroborate 
that hypothesis and support further studies. 
3.2. A model for limb-to-limb IPG measurements 
Limb-to-limb IPG measurements are the aggregated contribution of impedance changes in the 
different body segments along the current path hence the logical steps to build a model are first to 
identify the current path and afterwards to calculate the effect of impedance changes in each 
segment. 
The IPG should theoretically rely only on physiological properties of the large arteries, as only 
these have a pulsatile behavior, which decreases to a steady flow in the smaller arteries and 
capillaries. However, some of the current injected can flow through adjacent tissues or fluids with 
non-pulsatile behavior such as veins, muscles, or fat causing a decrease of sensitivity on the 
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different segments of the current path. Therefore, as the amount of non-pulsatile tissue 
surrounding arteries in limb-to-limb measurements is different along the current path, it cannot be 
assumed that the sensitivity is evenly distributed. 
Table 3.1, adapted from [111], summarizes the electrical properties of some of the human body 
tissues and fluids that can be found in the current path from limb-to-limb. 
Table 3.1.  Summary of electrical properties of human body tissues and fluids, adapted from [111]. 
Tissue Conductivity (S/m) at low frequencies 
 (from 1 Hz to 10 kHz) 
Anisotropy 
Human skin, dry 10-7 Unknown 
Human skin, wet 10-5 Unknown 
Bone 0.005-0.06 Strong 
Fat 0.02-0.05 Small 
Lung 0.05-0.4 Local 
Brain (grey matter) 0.03-0.4 Small 
Brain (white matter) 0.03-0.3 Strong 
Liver 0.2 Unknown 
Muscle 0.05-0.4 Strong 
Whole blood 0.7 Flow dependent 
Urine 0.5-2.6 No 
Cerebrospinal fluid 1.6 No 
 
Blood conductivity is at least an order of magnitude higher than that of the other tissues and 
fluids that can be found in limbs excluding muscles, whose maximal conductivity is about half that 
of the blood. As muscles constitute mostly of the cross-section in human limbs it could be 
expected that a significant amount of current would flow through them.  
However, limbs are complex structures and cannot be analyzed as a simple aggregation of 
tissues. Individual muscles are surrounded by the fascia, a large macromembrane that separates 
them from each other, and are connected to bones through tendons. These structures show much 
higher impedance than the muscular tissue itself and increase the impedance of muscles from end 
to end. Further, muscular tissue is strongly anisotropic, which means that its conductivity is 
dependent on the direction of the current. As muscular cells are stretched, the current crosses a 
higher number of cellular membranes when traveling in perpendicular direction, which show higher 
impedance [111] and hinder the current flow to adjacent tissues. 
On the other hand, blood vessels offer a continuous low-impedance path along the human 
body, which suggests that a significant amount of electric current injected between two limbs will 
flow through them. Consequently, variations of the amount of tissue surrounding large arteries 
have a small effect and the current flowing through them during the cardiac cycle can be assumed 
constant. 
Considering only the influence of the large arteries, the measurement sensitivity is dominated 
by two phenomena reflected in equation (2.6). First, the increase of impedance is inversely 
proportional to the square of the cross-sectional area hence a given cross-sectional area change in 
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distal arteries will have a higher impact on the total measured impedance, as the cross-sectional area 
decreases from proximal to distal sites. 
Second, the increase of impedance is proportional to the increase of cross-sectional area, which 
is related to the increase of pressure by the particular geometry and elasticity of the artery. The 
compliance C of an artery defines the ratio of increase of cross-sectional area ΔA per increase of 
pressure ΔP, and depends on the elastic modulus E, radius r, and wall thickness h of the artery 
[112], according to 
  
  
  
 
    
  
  
(3.1) 
The elastic modulus increases from proximal to distal arteries as a result of the decrease of the 
relative amount of elastic tissue whereas the vessel radius and wall thickness decrease [113]. In 
consequence, compliance decreases from proximal to distal arteries, which implies that pressure 
changes in proximal arteries result in higher increases of volume than in proximal sites. 
The cross-sectional sensitivity of an artery S, defined as the ratio of increase of resistance ΔR 
per increase of pressure ΔP per unit length l, can be obtained from equations (2.6) and (3.1) 
according to 
  
  
   
 
     
  
 
   
 
     
    
 
    
  
 
    
   
  
(3.2) 
where ρe is the resistivity of blood, which is typically 1.43 Ω m (see Table 3.1). 
Therefore, the sensitivity in a body segment is a tradeoff between arterial cross-sectional area 
and compliance, which have opposite effects in proximal and distal vessels and whose dominance 
can only be calculated from real physiological data. Reference values of radius, wall thickness, and 
length can be obtained from corpses [114] whereas the elastic modulus to obtain the compliance 
can be calculated from the arterial distensibility D measured in vivo [115], according to  
  
       
  
  
(3.3) 
where 0.75 is a correction coefficient to compensate for the thickness of the arterial wall [116], 
which is assumed to be much smaller than r in equation (3.3).  
3.3. Time intervals from the hand-to-hand IPG 
Fig. 3.1 shows the large arteries that can be found in the current path from hand to hand, 
adapted from [114]. 
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Fig. 3.1.  Large arteries in the current path from hand to hand, adapted from [114]. 
According to the observations made in section 3.2, the most of the current injected from hand 
to hand flows through the deep and superficial palmar arches, radial artery, ulnar artery, brachial 
artery, subclavian artery, brachiocephalic artery, and the aortic arch. Table 3.2 summarizes the 
physiological parameters of these arteries and others involved in the propagation of the pressure 
pulse measured from real subjects in [114] and [115]. An additional coefficient x is used to 
represent the fraction of the total current flowing through each large artery, which has been 
calculated by modeling arteries in parallel as parallel resistors. 
Table 3.2.  Physiological properties of the large arteries involved in the hand-to-hand IPG 
measurement, extracted from [114] and [115]. 
Artery r (cm) h (cm) l (cm) D (10-3 mmHg-1) E (106 Pa) x (Ø) 
Ascending aorta 1.470 0.163 4.0 5.49 0.33 0 
Aortic arch 1.263 0.126 2.0 5.32 0.38 0.5 
Brachiocephalic 0.699 0.080 3.4 3.30 0.53 0.5 
Subclavian 0.541 0.067 3.4 3.08 0.52 1 
Brachial 0.515 0.067 42.2 2.09 0.74 1 
Radial 0.367 0.043 23.5 1.21 1.41 0.41 
Ulnar A 0.454 0.046 6.7 1.25 1.58 0.59 
Ulnar B 0.433 0.046 17.1 1.13 1.67 0.59 
 
The cross-sectional sensitivity of the large arteries in the current path from hand to hand, 
calculated from equation (3.3) and the data in Table 3.2, is shown in Fig. 3.2. 
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Fig. 3.2.  Cross-sectional sensitivity of the large arteries in the current path from hand-to-hand. 
The cross-sectional sensitivity is low in proximal arteries due to their high cross-sectional area 
and in distal arteries due to their low compliance whereas the best trade-off is found in the 
subclavian artery. As the available data does not include the palmar arch, its sensitivity cannot be 
calculated although it is expected to decrease according to the trend observed in Fig. 3.2. Arterioles 
have less elastic tissue than larger arteries and capillaries have no elastic tissue at all and therefore 
their cross-sectional sensitivity is expected to be negligible. 
The system response to an impulse-shaped pressure pulse traveling through an artery has a base 
equal to the length of the artery divided by the PWV and a height equal to the cross-sectional 
sensitivity multiplied by the PWV, which can be calculated from several physiological properties of 
the arteries and the blood density ρb (1060 kg/m3) by using the Moens-Korteweg equation 
    √
  
    
  
(3.4) 
The total impulse response of the system h(t) is the concatenated response of the different large 
arteries in the current path, as shown in Fig. 3.3. 
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Fig. 3.3.  Impulse response of the hand-to-hand IPG. 
PWV compensates for the decrease of sensitivity in distal arteries and the system response is 
almost flat, which implies that the measured waveform is a summation of pressure changes along 
the path from the brachiocephalic artery to the end of the radial and ulnar arteries. The shape of 
h(t) can be approximated to the impulse response of a delayed rectangular window filter hence it is 
expected to cause a delay and low-pass filter to the input signal. However, the length of the impulse 
response of the hand-to-hand IPG depends on the PWV, which changes with the mean BP, and 
the time dependency of h(t) can only be properly evaluated by simulation. 
The upstroke of the hand-to-hand IPG has been simulated by convoluting h(t) with a synthetic 
waveform x(t), defined as 
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(3.5) 
which has been selected for having a shape similar to that typical pressure-pulse upstrokes [117], 
assuming that the pressure pulse waveform remains unaltered at the upstroke during the 
propagation.  
Fig. 3.4 shows the simulated upstroke of the hand-to-hand IPG with other simulated local IPG 
upstrokes obtained from different reference sites such as the shoulder (end of the subclavian 
artery), elbow (end of the brachial artery), and the wrist (end of the radial and ulnar arteries). 
Waveforms amplitudes are normalized with respect to their respective maximum to ease their 
comparison. 
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Fig. 3.4.  Simulated hand-to-hand IPG upstroke and local IPG upstrokes at the shoulder, elbow, and 
the wrist. 
As expected from the impulse response in Fig. 3.3, the hand-to-hand IPG upstroke is 
smoothed compared to other local IPG waveforms, especially in the area of the pulse foot, which 
indicates that the signal is sensitive to changes in proximal vessels in this area. 
The elastic modulus E, which according to (3.4) affects PWV, can be related to the mean blood 
pressure P [118], according to 
     
    (3.6) 
where E0 is the elastic modulus at reference mean BP and ξ is a constant that depends on the 
particular vessel and ranges from 0.016 mmHg-1 to 0.018 mmHg-1. Fig. 3.5 shows several hand-to-
hand IPG waveforms simulated for different values of mean BP normalized with respect to their 
maximum. E0 has been obtained from Table 3.2, which values correspond to P = 100 mmHg, and ξ 
is assumed to be 0.017 mmHg-1. Higher pressures yield faster upstrokes but otherwise the foot 
undergoes minimal change. 
 
Fig. 3.5.  Simulated hand-to-hand IPG upstrokes for different mean BP values. 
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Changes in mean BP are mostly reflected on the slope of the upstroke of the hand-to-hand 
IPG although the foot of the wave is also slightly delayed.  
The pressure-pulse timing was measured in the simulated waves for different values of mean 
BP by using the intersecting tangents method and the results were compared to the pressure-pulse 
timing of the simulated wrist and carotid (end of the brachiocephalic artery) IPG. Fig. 3.6 shows 
the PTT measured from cardiac ejection to the simulated hand-to-hand, carotid, and wrist IPG. 
 
Fig. 3.6.  PTT from the opening of the aortic valve to the simulated hand-to-hand, carotid, and wrist 
IPG. 
The sensitivity of the pressure-pulse timing to changes in the PTT caused by changes in BP is 
lower than the sensitivity of the pressure-pulse timing at the finger and similar to the sensitivity of 
the pressure-pulse at the carotid, despite of the higher offset. This low sensitivity with respect to 
the higher delay can be attributed to the change in slope that counteracts the displacement of the 
foot of the wave when using the tangent intersection method. Consequently, the interval from the 
ECG R wave to the hand-to-hand IPG pressure-pulse timing using this method includes the PEP 
(see Fig. 1.3) plus a constant delay weakly sensitive to the PTT hence constitutes a good candidate 
to estimate changes in the PEP, as it is commonly performed with the carotid PAT [119] or the 
earlobe PAT [120]. 
3.3.1. Hand-to-hand IPG model verification 
This model for the hand-to-hand IPG has been verified by a novel four-electrode system able 
to simultaneously obtain the ECG and the hand-to-hand IPG [P1]. The IPG system was built 
according to the design described in section 2.2.3, which was adapted to hand-to-hand 
measurements by setting the gain of the instrumentation amplifier to 10. The ECG system was built 
according to the design described in section 2.1.3. The current injection electrodes were contacted 
by index fingers whereas the measurement electrodes were contacted by middle fingers. An 
additional IPG obtained from the system described in section 2.2.3 was used to measure 
simultaneous reference pressure-pulse waveforms at the shoulder, elbow, wrist, and the finger by 
using the current injected by the hand-to-hand IPG system, as shown in Fig. 3.7. 
  
 
64         Assessment of trends in the cardiovascular system 
 
Fig. 3.7.  Measurement setup for hand-to-hand IPG model verification. 
The signals, which were acquired and sent to a PC using the system described in section 2.4.1, 
were sequentially recorded from a single subject for 10 s from each reference site. Fig. 3.8 shows a 
sample of the IPG waveforms obtained, normalized with respect to its maximum and synchronized 
with respect to the R wave of the ECG.  
 
Fig. 3.8.  Simultaneous hand-to-hand IPG and local IPG at the shoulder, elbow, wrist, and the finger. 
The shoulder IPG is delayed with respect to the simulated waveforms in Fig. 3.4, perhaps 
because the beginning of the brachial artery (in the shoulder) is not accessible with surface 
electrodes. The elbow IPG upstroke precedes the hand-to-hand IPG upstroke, which indicates that 
impedance changes at distal sites are slightly underestimated by the model. This can be attributed to 
the pressure pulse amplification in distal sites [121], which has been not included in the model. 
Another plausible explanation could be the lower proportion of tissues such as muscle or fat 
surrounding distal arteries, which could cause an increase of current flowing through it and justify 
this increased sensitivity. However, the signal obtained still reflects the smoothed foot and the 
slower slope of the upstroke, which suggests that the waveform is sensitive to changes in proximal 
sites and supports the validity of the assumptions made for the design of the model. 
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3.3.2. Assessment of PEP changes from the ECG and the hand-to-hand IPG 
The performance of the PAT to the hand-to-hand IPG in assessing changes in the PEP 
suggested by the model has been evaluated in 14 healthy subjects. The hand-to-hand IPG and the 
ECG were obtained from the four-electrode system described in section 3.3.1 whereas reference 
changes in the PEP were obtained from the PAT to the PPT system described in section 2.4.3 
placed over the left carotid artery. Even though the PAT to this artery includes about 30 ms of PTT 
[122], this site has proven to be a good surrogate for the measurement of changes in PEP [119] and 
is the proximal reference site specified in the standard aortic PTT measurement [17]. Since an 
increase of PTT can be related to an increase in mean BP according to 
         (√ (         )   ), (3.7) 
derived from equations (3.4) and (3.6), a large change in mean BP of 40 mmHg would result in a 
decrease in carotid PAT of only 8.5 ms, which implies that the interval is mostly dominated by 
changes in the PEP. An additional reference PAT to the left annular finger was obtained from the 
PPG system described in section 2.4.2. Fig. 3.9 shows the measurement setup for the assessment of 
changes in the PEP from the ECG and the hand-to-hand IPG. 
 
Fig. 3.9.  Measurement setup for the assessment of PEP changes from the ECG and the hand-to-
hand IPG. 
In order to induce hemodynamic changes, the subjects were asked to perform a paced 
respiration maneuver at 0.1 Hz for 50 s. The signals were acquired and sent to a PC using the 
system described in section 2.4.1. The ECG R-wave timing was measured by applying a modified 
Pan-Tompkins algorithm, whereas pressure-pulse timings were measured by applying the tangent 
intersection method. 
Fig. 3.10 shows an example of the finger, hand-to-hand, and carotid PAT traces obtained 
during the experiment. 
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Fig. 3.10.  Example of the finger, hand-to-hand, and carotid PAT traces obtained during paced 
respiration. 
From the amplitude and phase of the carotid PAT and the finger PAT traces, it follows that 
paced respiration induces changes in the PEP, as it has been previously reported for other short-
term maneuvers [72]. As predicted by Fig. 3.6, the hand-to-hand PAT is longer than the carotid 
PAT and shorter than the finger PAT. However, these timings cannot be considered an absolute 
reference as the PPG and the PPT have an offset caused by the contact pressure, described in 
section 2.2.4 and reported in [12]. The mean of the correlation coefficients between the hand-to-
hand PAT and the carotid PAT was 0.72 with a standard deviation of 0.14 whereas the mean of the 
correlation coefficients between hand-to-hand PAT and finger PAT was 0.76 with a standard 
deviation of 0.12. A total of three carotid PAT recordings and two finger PAT recordings were 
excluded for having p > 0.05 attributable to excessively soft hemodynamic changes induced by 
paced respiration.  
Fig. 3.11 shows the aggregated 780 hand-to-hand PAT and carotid PAT pairs of values 
obtained from the 14 subjects during the experiment. 
 
Fig. 3.11.  Hand-to-hand PAT vs. carotid PAT, and Bland Altman analysis of hand-to-hand PAT vs. 
carotid PAT during paced respiration. 
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The correlation between the hand-to-hand PAT and the carotid PAT is strong and the slope of 
the regression line is close to 1, which proves that the sensitivity of the hand-to-hand PAT to PEP 
changes is high. The offset is higher than the model prediction in Fig. 3.6, perhaps as a result of the 
underestimation of sensitivity in distal sites already observed in Fig. 3.8. 
The standard deviation of the difference between the hand-to-hand PAT and the carotid PAT 
during paced respiration was 7.6 ms, which is twice as large as the standard uncertainty of 3.3 ms 
reported when using the IPG as a surrogate of the PPG in section 2.2.4. This larger uncertainty can 
be attributed to a higher degree of motion artifacts on the carotid PPT signal, which is especially 
sensitive to subtle head and neck movements performed during respiration. Further, the non-zero 
sensitivity to PTT changes in both the carotid PPT and hand-to-hand IPG signals cause small 
displacements of the measured points and increase the uncertainty. 
Fig. 3.12 shows the aggregated 780 hand-to-hand PAT and finger PAT pairs of values obtained 
from the 14 subjects during the experiment. 
 
Fig. 3.12.  Hand-to-hand PAT vs. finger PAT, and Bland Altman analysis of hand-to-hand PAT vs. 
finger PAT during paced respiration. 
Even though the correlation between the hand-to-hand PAT and the finger PAT is still strong 
[C5], the slope of the regression line is lower than 1, thus suggesting that the finger PAT includes a 
higher amount of PTT that changes synchronously with PEP changes and causes a displacement of 
the pairs of values to the right. Therefore, it can be concluded that the hand-to-hand PAT reflects 
the arrival of the pressure pulse at proximal sites rather than distal sites even though it is obtained 
from distal electrodes. 
3.4. Time intervals from the foot-to-foot IPG 
Fig. 3.13 shows the large arteries that can be found in the current path from foot to foot, 
adapted from [114]. 
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Fig. 3.13.  Large arteries in the current path from foot to foot, adapted from [114]. 
According to the observations made in section 3.2, the most of the current injected from foot 
to foot flows through the pedal arch, anterior tibial artery, posterior tibial artery, femoral artery, 
external iliac artery, and the common iliac artery. Table 3.3 summarizes the physiological 
parameters of these arteries and others involved in the propagation of the pressure pulse measured 
from real subjects in [114] and [115]. An additional coefficient x is used to represent the fraction of 
the total current flowing through each artery, which has been calculated by modeling arteries in 
parallel as parallel resistors. 
Table 3.3.  Physiological properties of the large arteries involved in the foot-to-foot IPG 
measurement, extracted from [114] and [115]. 
Artery r (cm) h (cm) l (cm) D (10-3 mmHg-1) E (106 Pa) x (Ø) 
Ascending aorta 1.470 0.163 4.0 5.49 0.33 0 
Aortic arch 1.229 0.120 5.9 5.30 0.39 0 
Thoracic aorta 1.096 0.105 15.6 4.58 0.46 0 
Abdominal aorta 0.770 0.078 18.9 4.01 0.49 0 
Common iliac 0.470 0.060 5.9 3.10 0.51 1 
External iliac 0.482 0.053 14.5 2.84 0.64 1 
Femoral 0.361 0.050 44.4 2.44 0.59 1 
Posterior tibial 0.375 0.045 32.2 1.41 1.18 0.79 
Anterior tibial 0.197 0.039 34.4 1.24 0.85 0.21 
 
The cross-sectional sensitivity of the large arteries in the current path from foot to foot, 
calculated from equation (3.3) and the data in Table 3.3, is shown Fig. 3.14. 
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Fig. 3.14.  Cross-sectional sensitivity of the large arteries in the current path from foot-to-foot. 
Unlike the IPG from hand to hand, proximal arteries have no influence on the foot-to-foot 
IPG. Even though the sensitivity increases when approaching to more distal arteries, the difference 
is not as high as in the hand-to-hand measurement. 
The total impulse response of the system h(t), calculated as the concatenated response of the 
different large arteries in the current path, is shown in Fig. 3.15. 
 
Fig. 3.15.  Impulse response of the foot-to-foot IPG. 
Similarly to the hand-to-hand IPG, the PWV compensates for the decrease of sensitivity in 
distal arteries and the system response is similar to the system response of a delayed rectangular 
window filter, which implies that the measured waveform is sensitive to the summation of pressure 
changes along the path from the common iliac artery to the end of the tibial arteries, and is 
expected to be smoothed and delayed with respect to the BP waveform. 
Fig. 3.16 shows the simulated upstroke of the foot-to-foot IPG with other simulated local IPG 
upstrokes obtained from different reference sites such as the femoral artery (end of the external 
iliac artery), knee (end of the femoral artery), and the ankle (end of the anterior and posterior tibial 
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arteries). The waveforms are normalized with respect to their respective maximum to ease the 
comparison. 
 
Fig. 3.16.  Simulated hand-to-hand IPG upstroke and local IPG upstrokes at the femoral artery, knee, 
and the ankle. 
Similarly to the hand-to-hand IPG, the rectangular shape of the transfer function causes a 
smoothening of the foot-to-foot IPG upstroke and there is also some change in the foot of the 
wave. 
Fig. 3.17 shows several foot-to-foot IPG upstrokes simulated for different values of BP. The 
same as with the hand-to-hand IPG, when the mean BP increases the slope of the upstroke of the 
foot-to-foot IPG also increases, but here the displacement of the foot of the wave is significantly 
higher. 
 
Fig. 3.17.  Simulated foot-to-foot IPG waveforms for different mean BP values. 
Fig. 3.18 shows the pressure-pulse timing measured from the simulated waves for different 
values of mean BP compared to the pressure-pulse timing of the simulated femoral and ankle IPG. 
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Fig. 3.18.  PTT from the opening of the aortic valve to the simulated foot-to-foot, femoral artery, and 
ankle IPG. 
Unlike the hand-to-hand IPG, the pressure-pulse timing of the foot-to-foot IPG is sensitive to 
PTT changes caused by changes in mean BP although its dependence is similar to that of the 
femoral pressure-pulse timing rather than to the ankle pressure-pulse timing. Therefore, the foot-
to-foot PAT is of great interest as it could be used to assess changes in the femoral pulse, which is 
one of the reference sites specified by the gold standard measurement of arterial stiffness [17]. 
3.4.1. Foot-to-foot IPG model verification 
The foot-to-foot IPG model has been verified by a four-electrode system built according to the 
design described in section 2.2.3, which was adapted to foot-to-foot measurements by setting the 
gain of the instrumentation amplifier to 10. Each current injection electrode was contacted by one 
forefoot whereas each measurement electrode was contacted by one heel. The ECG was 
simultaneously obtained from the system described in section 2.1.3 connected to the left and right 
hands. An additional IPG obtained from the system described in section 2.2.3 was used to measure 
simultaneous reference pressure-pulse waveforms at the femoral artery, knee, and the ankle by 
using the current injected by the foot-to-foot IPG system, as shown in Fig. 3.19. 
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Fig. 3.19.  Measurement setup for foot-to-foot IPG model verification. 
The signals, which were acquired and sent to a PC using the system described in section 2.4.1, 
were sequentially recorded from a single subject for 10 s from each reference site. Fig. 3.20 shows a 
sample of the IPG waveforms obtained, synchronized from the ECG R wave.  
 
Fig. 3.20.  Simultaneous foot-to-foot IPG and local IPG at the femoral artery, knee, and the ankle. 
The femoral, knee and ankle IPG waveforms are roughly comparable to those simulated in Fig. 
3.16 with regard to the timing of the wave foot and the slope of the upstroke. The foot-to-foot IPG 
waveform, however, is considerably delayed as compared to the upstrokes simulated in Fig. 3.16. It 
seems that, similarly to the hand-to-hand IPG, the model underestimates changes in distal sites, 
which can be as well attributed to the pressure pulse amplification phenomena or to a lower 
proportion of tissues surrounding distal arteries. However, the effect is higher in this case and the 
foot of the waveform obtained is not as smoothed as it was in the hand-to-hand waveform whereas 
the slope of the upstroke is similar to that of the three local IPG waveforms. 
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3.4.2. Assessment of the femoral PAT from the ECG and the foot-to-foot IPG 
The performance of the foot-to-foot IPG to determine the arrival of the pressure pulse at the 
femoral artery suggested by the model has been evaluated on three healthy subjects, which were 
asked to perform a paced respiration maneuver at 0.1 Hz for 100 s in order to induce hemodynamic 
changes. The ECG, foot-to-foot IPG, and a femoral IPG were obtained by the measurement setup 
shown in Fig. 3.19. The signals were acquired and sent to a PC using the system described in 
section 2.4.1. The ECG R-wave timing was measured by applying a modified Pan-Tompkins 
algorithm whereas pressure-pulse timings were measured by applying the tangent intersection 
method. 
Fig. 3.21 shows an example of the femoral PAT and foot-to-foot PAT traces obtained during 
the experiment. 
 
Fig. 3.21.  Example of the foot-to-foot PAT and femoral PAT traces obtained during paced 
respiration. 
The same as in Fig. 3.20, the foot-to-foot PAT is significantly longer than the femoral PAT 
hence the foot-to-foot IPG cannot be used as a direct surrogate of the femoral pulse. However, 
individual correlations were strong, with correlation coefficients of 0.93, 0.86, and 0.89 respectively.  
Fig. 3.22 shows the aggregated 408 foot-to-foot PAT and femoral PAT pairs of values obtained 
from the 3 subjects during the experiment and the Bland-Altman analysis. 
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Fig. 3.22.  Foot-to-foot PAT vs. femoral PAT, and Bland-Altman analysis of foot-to-foot PAT vs. 
femoral PAT during paced respiration. 
The correlation between foot-to-foot PAT and femoral PAT is strong and the slope of the 
regression line is close to 1, which proves that the sensitivity of the foot-to-foot PAT to changes in 
PEP and PTT is similar to that of the femoral pulse even though the offset is higher for the foot-
to-foot PAT. The standard deviation of the difference between foot-to-foot PAT and femoral PAT 
during paced respiration was 3.8 ms, which is not significantly larger than the standard uncertainty 
of 3.3 ms reported when using the IPG as a surrogate of the PPG in section 2.2.4.  
3.5. Summary 
This chapter has been devoted to the measurement of time intervals from the IPG measured 
from hand to hand and from foot to foot, which had never been analyzed before. First, we studied 
how the different body segments along the current path contribute to the measured signal. We have 
found that the contribution of the large arteries relies on the tradeoff between arterial cross-
sectional area and compliance, which have opposite effects in proximal and distal vessels. As a 
result of this, the upstrokes of the measured waveforms reflect the pressure-pulse arrival to 
proximal sites but after a constant delay. 
Second, we have found that the PAT to the hand-to-hand IPG reflects changes in the PEP 
rather than in the PTT and can be used as a surrogate of the carotid PAT with an uncertainty below 
the uncertainties reported for other pressure-pulse timing measurements [29][30][31][32] that are of 
the order of tens of milliseconds. This measurement is of great interest since the carotid PAT is the 
proximal reference signals in standard aortic PTT measurements and can be obtained from the 
timing of the hand-to-hand IPG by a single-point calibration to account for a constant delay. The 
performance of the PAT to the hand-to-hand IPG was analyzed from a novel four-electrode 
system able to simultaneously obtain the ECG and the IPG, which is especially suitable for 
monitoring devices due to its reduced number of electrodes. 
Finally, we have found that the sensitivity of the foot-to-foot IPG pressure-pulse timing to 
changes in PEP and aortic PTT is similar to that of the femoral PAT, which is the distal reference 
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signal in standard aortic PTT measurements. The foot-to-foot PAT can be used as a surrogate of 
femoral PAT with a standard uncertainty below the uncertainties reported for other pressure-pulse 
timing measurements, although the interval includes an offset that must be calibrated. 
Further, since the IPG signals analyzed do not suffer from any delays introduced by the sensor 
contact pressure, these constitute a more reliable tool for pressure-pulse timing measurements while 
the need of calibration to measure intervals such as the PTT does not represent a major drawback, 
as these often require calibration in any case. Further, IPG signals are obtained from electrodes, 
which can be easily embedded in common objects and shared with other systems, hence these are 
especially suited for cardiovascular parameter measurements in ambulatory scenarios.  
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Chapter 4  
Time intervals from the BCG 
HE measurement of time intervals between the weighing-scale BCG and other signals to 
obtain cardiovascular parameters is a promising field as the signal can be noninvasively 
obtained from simple and cost-effective weighing scales in ambulatory scenarios. Due to the 
abundance of motion artifacts typically present BCG recordings from standing subjects, most of 
the efforts carried out until now focus on the measurement of the J-wave timing, which is the most 
prominent feature of the BCG and therefore has the highest SNR, as a surrogate measurement of 
the cardiac-ejection timing. However, the particular intra-waveform dynamics of the weighing-scale 
BCG have not been yet reported and could be sensitive to other cardiovascular parameters. This 
chapter analyzes the performance of the I wave as a surrogate of the cardiac-ejection timing and the 
response of the IJ interval to changes in the PTT. Finally, the performance of the interval from the 
BCG I wave to the foot-to-foot IPG pressure-pulse timing in assessing the aortic PTT is evaluated. 
4.1. The relative timing of the BCG waves  
The development of several BCG systems embedded in weighing scales [66] in the last years 
has prompted a renewed interest on this signal because these devices are already common in the 
daily routine of many homes and are periodically used to monitor the health status from the body 
weight. 
The BCG waveform is originated from the forces caused by cardiac ejection of blood hence 
any interval measured from the ECG QRS complex to the BCG depends on the PEP, the time 
from the electric activation of the heart to the beginning of cardiac ejection (see Fig. 1.3). As the 
physiological origin of the BCG waves is still controversial, the J wave is usually the reference BCG 
T 
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waveform feature used to assess the PEP because its SNR is higher than that of other BCG waves. 
The capability of the RJ interval, measured from the ECG R wave instead of the Q wave because of 
its higher SNR, in assessing the PEP [70] and contractility [71], which is inversely proportional to 
the PEP under stable conditions of preload and afterload, is good. The RJ can also be used to 
assess changes in systolic BP [14], which are strongly correlated with changes in PEP during short 
effort tests [72], and the strong correspondence between the RJ interval and systolic BP during the 
four phases of a Valsalva maneuver was reported in [C6]. 
Despite of the strong correlations reported, the performance of the RJ interval in assessing the 
PEP relies on the underlying hypothesis that the timing from cardiac ejection to the J wave is 
constant, which is not supported by any reported model or systematic observation and cannot be 
assumed to be true in all circumstances. BCG waves result from a superposition of forces caused by 
events during the propagation of the pressure-pulse along the arterial tree hence it is reasonable to 
assume that the later waves, which are originated by events in distal sites, are dependent on the 
PTT besides of the cardiac-ejection timing. Fig. 4.1 shows a representation of the ECG, BCG, and 
the BP at the aorta, carotid, and femoral arteries with different intervals of interest measured 
between its waves. 
 
Fig. 4.1.  Representation of the ECG, aortic BP, carotid BP, femoral BP, and the BCG. 
The RJ interval typically lasts about 210 ms [106] whereas the PEP usually lasts about 100 ms 
[18]. If it is assumed that the interval between the Q and R is roughly half of the QRS, which 
typically lasts about 80 ms [18], the J-wave timing appears to be about 150 ms later than the 
opening of the aortic valve, which is similar than the pressure-pulse timing at the finger or the 
femoral artery (see Fig. 3.8 and Fig. 3.20) and suggests that the wave is influenced by the PTT in 
addition to the PEP. 
Earlier waves such as the H wave and the I wave should include a lesser amount of PTT and 
better assess the cardiac-ejection timing. However, the H wave, whose use to assess the PEP was 
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suggested in [74] and is nearly simultaneous with the aortic valve opening, is better attributed to 
ventricular movements due to its absence in recordings without ventricular contraction [75]. 
Alternatively, the I-wave timing is typically about 90 ms after the ECG R wave [106], which is only 
about 30 ms after cardiac ejection and is similar to the pressure-pulse timing at the carotid artery 
(see Fig. 3.10), hence it is reasonable to assume that the I-wave timing is less influenced by 
superposed earlier waves and the PTT. Therefore, the I-wave timing should assess the cardiac-
ejection timing better than the J-wave timing in spite of the higher SNR of this wave.  
Further, the observations made above imply that the difference in timings of the I and J waves 
of the BCG, that is, the IJ interval, should be sensitive to the PTT in a manner analogous to other 
timing measurements from other proximal to distal signals. Therefore, as the I-wave timing and the 
J-wave timing are dependent to the carotid ejection timing and the J wave presumably includes a 
higher amount of PTT, it is reasonable to assume that the difference is sensitive to the PTT, and 
more particularly to changes in aortic PTT, as the greatest vertical forces recorded in the 
longitudinal BCG are originated there. The different dynamics of the RJ, RI, and IJ intervals during 
a paced respiration maneuver reported in [C7] suggest that the intervals could be sensitive to 
different cardiovascular parameters. 
Finally, the ability of the BCG in assessing the cardiac-ejection timing has still not been fully 
exploited since the signal can be used to measure the PTT combined with a distal pressure-pulse 
waveform integrated in a weighing scale such as an IPG. Similar measurement have not been 
performed until very recent times [76], even though some systems reported are theoretically capable 
of performing this measurement [15] and use the information from both signals to improve 
heartbeat detection [123][124]. The results reported in section 3.4.2 suggest that the IPG from foot-
to-foot is a very interesting signal that can be obtained from a weighing scale, as the pressure-pulse 
timing of this signal is insensitive to PTT changes in limbs and therefore the interval measured 
from the BCG I wave to it should be sensitive only to the aortic PTT, which is of great interest 
since this is currently the gold standard measurement of PTT for the assessment of regional arterial 
stiffness [17]. 
4.2. Cardiac-ejection timing assessment from the I wave of the BCG 
The validity of the RI interval to assess the cardiac-ejection timing has been evaluated in 14 
healthy subjects. The RI interval was obtained from the ECG system described in section 2.1.3 and 
the BCG system described in section 2.3.3 whereas reference cardiac-ejection timings were 
obtained from the PPT system described in section 2.4.3 placed over the left carotid artery. The 
pressure-pulse timing at this site is strongly sensitive to changes in the PEP compared to changes in 
the PTT, as explained in section 3.3.2. Fig. 4.2 shows the measurement setup for the assessment of 
the cardiac-ejection timing from the ECG and the BCG. 
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Fig. 4.2.  Measurement setup for the assessment of the cardiac-ejection timing. 
In order to induce hemodynamic changes, the subjects were asked to perform a paced 
respiration maneuver at 0.1 Hz for 50 s. The signals were acquired and sent to a PC using the 
system described in section 2.4.1. The ECG R-wave timing was measured by applying a modified 
Pan-Tompkins algorithm whereas the pressure-pulse timing was measured by applying the tangent 
intersection method to detect its foot. The I and J wave timings were measured from a windowed 
maximum and minimum detection algorithm in an ensemble average composed of three 
consecutive heartbeats, as described in section 2.3.4, to decrease the uncertainty of the timing 
measurement. 
The mean of the correlation coefficients between the RI interval and the carotid PAT was 0.71 
and the standard deviation was 0.16 whereas the mean of the correlation coefficients between the 
RJ interval and the carotid PAT was 0.37 and the standard deviation was 0.44. A total of six RI 
recordings and nine RJ recordings were considered not statistically significant and were excluded of 
these calculations for having p > 0.05. The reasons for these apparently weaker correlations 
compared to those reported between the RJ interval and the PEP reported during a Valsalva 
maneuver (0.87 [71], 0.93 [74]) can be better explained by examining the traces obtained during the 
experiments, a sample of which is shown in Fig. 4.3. 
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Fig. 4.3.  Example of the RJ interval, RI interval, and carotid PAT traces obtained during paced 
respiration. 
The RJ trace has a delay of about 5 heartbeats compared to the carotid PAT trace, which 
together with the high degree of motion artifacts typically found on standing BCG recordings 
obtained from weighing scales is responsible for the low correlation coefficients obtained. This 
delay was different for each subject, ranging from 0 to 6 heartbeats. 
A plausible explanation for the delay in RJ traces with respect to the carotid PAT is the 
hypothesized dependence of the RJ interval on the PTT in addition to the PEP. During inspiration, 
the filling of air in the lungs expels blood to the systemic arterial system that raises the BP and 
shortens the PPT as a result of the increase of arterial elasticity (see equation (3.6)). This increase in 
pressure is counteracted by the hemodynamic regulation system by increasing the stroke volume of 
the right ventricle [125], which results in a shortening of the PEP. This regulation process takes a 
few heartbeats to stabilize and it could be responsible for the delay between PTT and PEP traces 
during paced respiration. In slower maneuvers that induce stronger hemodynamic changes in PEP, 
such as the Valsalva or tilt-up maneuvers, this delay is less perceptible and has a lesser effect on the 
correlation between the PEP and the RJ interval. It was also observed that subjects that performed 
excessively soft paced respiration maneuvers had a nearly constant PTT while the hemodynamic 
changes were only induced in the PEP. 
On the other hand, the carotid PAT and RI interval traces are almost synchronous, which 
explains the stronger correlation compared to the RJ interval, the small differences being 
attributable to the different PTT included in carotid PAT with respect to the RI interval or to other 
factors such as the overlap of the I wave with earlier waves.  
Fig. 4.4 shows the aggregated 804 RJ and carotid PAT pairs of values obtained from the 14 
subjects during the experiments. 
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Fig. 4.4.  RJ interval vs. carotid PAT, and Bland-Altman analysis of RJ interval vs. carotid PAT 
during paced respiration. 
The correlation between the RJ interval and carotid PAT during paced respiration increases 
significantly in the aggregated analysis but the delay between traces scatters the points around and 
this yields a low correlation coefficient and a higher σ in the Bland-Altman analysis compared to 
those reported during a Valsalva maneuver [71][74]. The slope, y-intercept, and mean of the Bland-
Altman analysis are consistent with the values reported in the literature. 
Fig. 4.5 shows the aggregated 804 RI and carotid PAT pairs of values obtained from the 14 
subjects during the same experiments. 
 
Fig. 4.5.  RI interval vs. carotid PAT, and Bland-Altman analysis of RI interval vs. carotid PAT 
during paced respiration. 
The correlation between the RI interval and carotid PAT during paced respiration also 
increases in the aggregated analysis and, despite of its lower SNR, the RI interval shows stronger 
correlation than the RJ interval during paced respiration, which suggests that the I wave is less 
influenced by the PTT and a better surrogate of the cardiac-ejection timing than the J wave. The RI 
interval can be used as a surrogate of the carotid PAT with a standard uncertainty of 6.9 ms, which 
is similar to the minimum uncertainty of 6.9 ms achieved in the J-wave timing in section 2.3.4, and 
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the low mean difference of only 12.1 ms implies that the measured timings do not require any 
calibration in applications where a low uncertainty is not required. 
4.3. Aortic PTT assessment from the IJ interval 
The validity of the IJ interval in assessing the aortic PTT has been evaluated in 3 healthy 
subjects. The IJ interval was obtained from the BCG system described in section 2.3.3 whereas 
reference aortic PTT values were obtained from the PPT system described in section 2.4.3 placed 
over the left carotid artery and the IPG system described in section 2.2.3 with the injection 
electrodes connected to the forefeet and the measurement electrodes placed about the beginning of 
the femoral artery. The ECG system described in section 2.1.3 was connected to the hands to be 
used as a timing reference. The IPGff was simultaneously obtained from the system described in 
section 3.4.1 with the injection electrodes connected to the forefeet and the detection electrodes 
connected to the heels for further use in section 4.4. Fig. 4.6 shows the measurement setup for the 
assessment of aortic PTT from the BCG. 
 
Fig. 4.6.  Measurement setup for the assessment of the PTT from the BCG. 
In order to induce hemodynamic changes, the subjects were asked to perform a paced 
respiration maneuver at 0.1 Hz for 100 s. The signals were acquired and sent to a PC using the 
system described in section 2.4.1. The ECG R-wave timing was measured by applying a modified 
Pan-Tompkins algorithm whereas the pressure-pulse timings were measured by applying the 
tangent intersection method to detect its foot. The I and J wave timings were measured from a 
windowed maximum and minimum detection algorithm in an ensemble average composed of three 
consecutive heartbeats, as described in section 2.3.4, to decrease the uncertainty of the timing 
measurement. 
The individual correlations between the IJ interval and the aortic PTT were moderate, with 
correlation coefficients of 0.65, 0.62, and 0.65. Unlike the correlations reported in section 4.2, these 
low values were a result of the abundant artifacts typically present on standing BCG rather than a 
consequence of any delay between traces, which was apparently zero.  
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Fig. 4.7 shows a sample of the traces obtained during the experiment. 
 
Fig. 4.7.  Sample of the IJ interval and aortic PTT traces obtained during paced respiration. 
The approximate synchronism between the IJ interval and aortic PTT traces during paced 
respiration suggests that the IJ interval strongly depends on the PTT and it is responsible for the 
low correlation between the RJ interval and the PEP during this maneuver, as reported in section 
4.2. The slightly larger changes in the IJ interval compared to the changes in the aortic PTT indicate 
that the IJ interval could be more sensitive to PTT than the aortic PTT, which can be attributed to 
the different overlap between the I and J waves during changes of the IJ interval.  
Fig. 4.8 shows the aggregated 407 IJ and aortic PTT pairs of values obtained from the 3 
subjects during the experiments. 
 
Fig. 4.8.  IJ interval vs. aortic PTT, and Bland-Altman analysis of IJ interval vs. aortic PTT during 
paced respiration. 
The correlation between the IJ interval and the aortic PTT during paced respiration slightly 
increases in the aggregated analysis but it is limited by the abundant motion artifacts present in 
BCG recordings compared to the range of variation in aortic PTT. The slope close to 1 and the low 
mean of the difference indicates that the IJ interval has a similar sensitivity to changes in arterial 
stiffness than the aortic PTT and can be used as a surrogate of aortic PAT without calibration in 
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applications where a low uncertainty is not required. The standard deviation of the difference 
between intervals is in the range expected from the uncertainties in the I-wave timing of 6.9 ms, 
and the J-wave timing of 6.9 ms reported in sections 4.1 and 2.3.4, respectively, and the general 
equation (2.4). 
4.4. Aortic PTT assessment from the BCG and the foot-to-foot IPG 
The validity of the time interval between the BCG I wave and the pressure-pulse timing of the 
foot-to-foot IPG in assessing the carotid PAT has been evaluated from the data collected in the 
experiments preformed to assess the aortic PTT from the IJ interval described in section 4.3. 
The individual correlations between the interval from the BCG I wave to the foot-to-foot IPG 
pressure-pulse timing, from here named PTTa_est, and the aortic PTT were moderately strong, with 
correlation coefficients of 0.52, 0.68, and 0.72, and slightly higher than the correlations between the 
aortic PTT and the IJ interval reported for the same recordings. Fig. 4.9 shows a sample of the 
traces obtained during the experiment for the same subject in Fig. 4.7. 
 
Fig. 4.9.  Sample of the PTTa_est and aortic PTT traces obtained during paced respiration. 
Despite of the offset between traces, the magnitude and phase of the changes induced by paced 
respiration is similar for both traces, which indicates that PTTa_est contains a similar amount of PTT 
than the aortic PTT and can be used as a surrogate by a single-point calibration. 
Fig. 4.10 shows the aggregated 407 PTTa_est and aortic PTT pairs of values obtained from the 3 
subjects during the experiments. 
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Fig. 4.10.  PTTa_est vs. aortic PTT, and Bland-Altman analysis of PTTa_est vs. aortic PTT during 
paced respiration. 
The correlation between the PTTa_est and aortic PTT during paced respiration somewhat 
improves in the aggregated analysis, and indicates that the performance of the PTTa_est as a 
surrogate of the aortic PTT is good. The mean and standard deviation of the difference is 
consistent with the values reported for the I-wave timing of 6.9 ms and the pressure-pulse timing of 
the foot-to-foot IPG of 3.9 ms in sections 4.2 and 3.4.2, respectively, and the general equation (2.4). 
4.5. Summary 
This chapter has been devoted to the measurement of several time intervals that involve BCG 
waves. First, we have proved that, in spite of its lower SNR, the I wave is a better marker of cardiac 
ejection than the commonly used J wave. We have found that the correlation between the RJ 
interval and the PEP under paced respiration is weaker than during alternative maneuvers such as 
the Valsalva’s, which indicates that the RJ interval includes, in addition to the PEP, a delay that 
cannot be assumed to be constant in all circumstances. On the contrary, the performance of the RI 
interval during the same experiments is significantly superior and the correlation coefficients and 
uncertainties obtained are similar to those previously reported between the RJ interval and the PEP 
under other maneuvers. These results suggest that the RI interval performs similarly to the RJ 
interval in a wider range of circumstances hence it constitutes a better option to assess the carotid 
ejection timing. Further, we have found that the RI interval can be used to assess the carotid PAT 
without any calibration hence it is a good candidate to be used as a surrogate of this proximal 
measurement. 
Second, we have found that the IJ interval is sensitive to changes in the PTT, which explains 
the worse performance of the RJ interval in assessing the PEP compared to the RI interval. The 
correlations found are moderately strong and the uncertainty is comparable to that of the aortic 
PTT measured with by other systems [29][30][31][32] that are of the order of tens of milliseconds. 
Even though the aggregate analysis suggests that the IJ interval could be a good surrogate of the 
aortic PTT without any calibration, individual traces show a slightly overestimation of the changes 
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in PTT that can be attributed to the change in overlap between the I and J waves and could require 
a calibration to properly estimate aortic PTT. These results are of particular interest since the 
dynamics of the BCG waves no yet explained is sensible to a parameter whose periodic monitoring 
is of great interest. 
Finally, we have proposed and tested a novel method to estimate the aortic PTT from the 
timing between the BCG I wave as a proximal site to the foot-to-foot IPG pressure-pulse timing as 
a distal site. The timing measurement between the BCG and a distal pressure-pulse waveform, not 
proposed until very recent times, constitute an optimal solution to assess the aortic PTT in 
ambulatory scenarios since both signals can be obtained from a weighing scale. This method yields 
a stronger correlation with aortic PTT and a lower standard uncertainty than the IJ interval even 
though the measured interval contains some offset, which could presumably be calibrated from the 
body height analogously to the estimation of the aortic length [126].  
These results can help in achieving a better comprehension of the physiological origin of the 
BCG waves, and reinforce the role of weighing scales as a tool for the noninvasive assessment of 
cardiovascular parameters in ambulatory scenarios.  
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Chapter 5  
Conclusions 
HE work presented in this thesis analyzes some systems and methods to assess cardiovascular 
parameters in ambulatory scenarios from the measurement of time intervals between or 
within the waves of physiological signals. Three signals, the ECG, IPG, and the BCG have been 
identified as the most suitable for that purpose as these can be acquired with simple, noninvasive, 
and cost-effective devices in ambulatory scenarios. Several cardiovascular parameters of interest can 
be assessed from time intervals between the proposed signals, some of them currently being used in 
research and clinical practice, since the signals contain information about different events associated 
to proximal and distal sites of the arterial tree. However, most of these intervals are measured in 
signals obtained from systems designed for broader purposes whose influence on the performance 
of timing measurements is often omitted. 
The first main goal of this work was to analyze the influence of the signal acquisition system on 
timing measurements from the proposed signals, in order to establish the repeatability of the 
intervals typically measured from it such as the PTT, PAT, or the PEP. Otherwise, the validity of 
the conclusions extracted from these intervals throughout this thesis or others in future works 
could be questionable.  
The second main goal was to propose novel methods to obtain cardiovascular parameters of 
interest using two signals whose physiological origin is still under debate: the IPG from limb to 
limb and the BCG. Due to the novelty of the hypotheses tested with respect to the prior knowledge 
about the signals, the objective was to prove the feasibility of the proposed measurements and to 
identify the main engineering challenges. 
T 
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The conclusions achieved during this thesis related to the main topics discussed and their 
implications are summarized below. 
Error sources in time interval measurements using cardiovascular signals 
The measurement of time intervals between physiological signals is a broad field with many 
applications of interest hence it is mandatory to know the factors that affect the reproducibility and 
repeatability of timing measurements. We have analyzed the effect of several parameters of the 
signal acquisition system such as the phase response of analog filters, noise level, sampling 
frequency, and the resolution of the ADC that can affect the uncertainty in timing measurements, 
and reported the minimal specifications for signal acquisition systems intended for time interval 
measurements in ambulatory scenarios. Further, we have designed and characterized custom signal 
acquisition systems that fulfill these specifications and are intended to be used as a reference in 
further works. 
Even though our methods were tested in small groups of subjects, the results reported show 
that whereas some uncertainties are unavoidable, others can be reduced with a careful design. The 
minimal requirements for signal acquisition systems found are not specially demanding yet some of 
the systems currently being used do not fulfill them, which degrades the uncertainty in their 
measurements. Conversely, some capabilities of common signal acquisition systems can be 
downgraded without degrading the uncertainty, which can contribute to design more cost-effective 
systems intended to be distributed in large population groups. 
The uncertainties measured throughout this document are in the range of milliseconds, which 
is significantly lower than typical uncertainties reported in time interval measurements and suggests 
that these could be much lower if they were obtained from systems especially intended for time 
interval measurements instead of general-purpose systems. Even though the results presented only 
include a limited number of subjects and the most common timing algorithms for each signal, the 
values reported constitute a reference value for systems intended for time interval measurements.  
Further, the evidence that timings obtained from the PPG are dependent to the sensor contact 
pressure found during the IPG characterization has strong implications, since the PPG is nowadays 
the most widely-used method to measure the pressure-pulse timing in clinical care. The results 
show that the uncertainty in timings from the PPG can be higher than the uncertainty introduced 
by the signal acquisition system. This, together with the inherent advantages of the IPG reinforces 
the role of this signal as a reliable tool for the pressure-pulse timing despite of its lower SNR as 
compared to the PPG.  
The IPG from limb to limb 
The limb-to-limb IPG has not received much attention and its only application is monitoring 
the heart rate in weighing scales. Compared to other pulsatile signals, it has the main advantage that 
it is obtained from electrodes that can be easily embedded in common objects of daily use such as a 
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phone case or a weighing scale. As the same electrodes can be shared with other systems to obtain 
other signals such as the ECG and the local IPG, the signal significantly increases the potential 
capabilities of multi-signal devices to assess cardiovascular parameters in ambulatory scenarios.  
We have hypothesized that the IPG from limb to limb is sensitive to changes in proximal sites 
even though it is obtained at distal sites, and we have proposed and evaluated a model to estimate 
the contributions of each body segment in the current path for the hand-to-hand and foot-to-foot 
IPG. After that, we have analyzed its validity to assess changes in the PEP and femoral PAT, two 
intervals of great interest since these can be used for the measurement of the aortic PTT. 
The strong correlation between the hand-to-hand IPG with the carotid pulse and the foot-to-
foot IPG with the femoral pulse found, strengthened by the model presented, show that the IPG 
from limb to limb can reflect changes in proximal sites with good uncertainty despite the need for 
offset calibration, which is otherwise common in several measurements based on time interval such 
as the PWV from the PTT. Combined with other signals obtained from distal sites that provide 
complementary information, the IPG from limb to limb substantially increases the spectrum of 
time intervals that can be measured noninvasively to assess cardiovascular parameters in ambulatory 
scenarios.  
Time intervals from the BCG 
The BCG has been known since long ago but the physiological origin of its waves is still 
controversial. We have hypothesized and demonstrated the enhanced performance of the RI 
interval compared to the RJ interval in assessing the PEP due to dependence of the IJ interval on 
the PTT, and we have proposed a novel method to assess the aortic PTT from the BCG and the 
foot-to-foot IPG. 
 The strong dependency of the I wave to cardiac ejection, and the strong correlation between 
the IJ interval and the aortic PTT found can help in achieving a better comprehension of the signal. 
The hypotheses formulated are simple enough to stand even without a model and the results 
suggest that several parameters of great interest can be obtained from the timings of the BCG 
waves. 
Combined with the diffusion of weighing scales in modern households, the results presented 
consolidate the role of weighing scales as a platform for multi-signal acquisition in ambulatory 
scenarios since the main parameters and signals targeted on this thesis can be acquired from 
systems integrated in them. Even though measurements from weighing scales are limited to only 
standing subjects, monitoring cardiovascular parameters in a daily basis is attractive enough to 
consider this new scenario for future approaches to cardiovascular disease treatment.  
The main results described above show that the initial objectives of this thesis have been  
achieved. Nevertheless, the work presented constitutes only a first step towards further research. As 
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described earlier, clinical trials should confirm some of the results obtained for a limited cohort. 
Further, some technical improvements could enhance the capabilities of the systems presented. 
First, the IPG has proved to be a reliable tool for pressure-pulse timing measurement, as it is 
almost insensitive to the sensor contact pressure. However, a low-noise design able to match the 
capabilities of common PPG systems would consolidate the IPG as the preferred option for time 
interval measurements. 
The BCG has shown a great potential in assessing cardiovascular parameters although these are 
strongly blurred by the high level of motion artifacts typically present on recordings. Reducing 
motion artifacts would increase the interest on the signal for cardiovascular parameter monitoring 
in ambulatory scenarios. 
Even though the ECG can be obtained in a weighing scale through a handheld device, a system 
to obtain it from the feet would turn weighing scales in a more integrated and easy-to-use solution. 
The increasing need for simple, noninvasive, and cost-effective solutions to provide a better 
medical access to the population defined the goals of this thesis. The systems and methods here 
described constitute a basis for the future development of platforms to monitor cardiovascular 
parameters in ambulatory scenarios and, hopefully, contribute to substantially improve life quality 
of healthy and diseased people in the world.  
 
  
 
93 References 
References 
[1] World Health Organization (WHO)  “World Health Statistics 2012 ” Geneve  2012  
[2] World Health Organization (WHO)  “Global Atlas of Cardiovascular Disease Prevention 
and Control ” Geneve  2011  
[3] J  T  Cohen  P  J  Neumann  and M  C  Weinstein  “Does Preventive Care Save Money? 
Health Economics and the Presidential Candidates ” N. Engl. J. Med., vol. 358, no. 7, pp. 
661–663, Feb. 2008. 
[4] World Health Organization (WHO)  “A Prioritized Research Agenda for Prevention and 
Control of Noncomunicable Diseases ” Geneve  2011  
[5] J  Allen  “Photoplethysmography and Its Application in Clinical Physiological 
Measurement ” Physiol. Meas., vol. 28, no. 3, Feb. 2007. 
[6] L. Sörnmo and P. Laguna, Bioelectrical Signal Processing in Cardiac and Neurological Applications, 
1st ed. Amsterdam, The Netherlands: Elsevier Academic Press, 2005. 
[7] J  Nyboer  M  M  Kreider  and L  Hannapel  “Electrical Impedance Plethysmography: a 
Physical and Physiologic Approach to Peripheral Vascular Study ” Circulation, vol. 2, no. 6, 
pp. 811–821, Dec. 1950. 
[8] O. T. Inan, P. F. Migeotte, K.-S. Park, M. Etemadi, K. Tavakolian, et al., 
“Ballistocardiography and Seismocardiography: a Review of Recent Advances ” Biomed. 
Heal. Informatics, IEEE J., pending publication, 2014. 
[9] R  M  Rangayyan and R  J  Lehner  “Phonocardiogram Signal Analysis: A Review ” Crit. Rev. 
Biomed. Eng., vol. 15, no. 3, pp. 211–236, 1987. 
[10] K  Matthys and P  Verdonck  “Development and Modelling of Arterial Applanation 
Tonometry: A Review ” Technol. Heal. Care, vol. 10, no. 1, pp. 65–76, Jan. 2002. 
[11] A. Grabovskis, Z. Marcinkevics, U. Rubins, and E. Kviesis-Kipge  “Effect of Probe Contact 
Pressure on the Photoplethysmographic Assessment of Conduit Artery Stiffness ” J. Biomed. 
Opt., vol. 18, no. 2, p. 27004, 2013. 
[12] X  F  Teng and Y  T  Zhang  “Theoretical Study on the Effect of Sensor Contact Force on 
Pulse Transit Time ” Biomed. Eng. IEEE Trans., vol. 54, no. 8, pp. 1490–1498, Aug. 2007. 
[13] R. Gonzalez-Landaeta, O. Casas, and R. Pallas-Areny  “Heart Rate Detection From Plantar 
Bioimpedance Measurements ” Biomed. Eng. IEEE Trans., vol. 55, no. 3, pp. 1163–1167, 
Mar. 2008. 
[14] J  H  Shin  K  M  Lee  and K  S  Park  “Non-constrained Monitoring of Systolic Blood 
Pressure on a Weighing Scale ” Physiol. Meas., vol. 30, no. 7, p. 679, 2009. 
[15] O  T  Inan  D  Park  G  T  A  Kovacs  and L  Giovangrandi  “Multi-Signal 
Electromechanical Cardiovascular Monitoring on a Modified Home Bathroom Scale ” in 
Engineering in Medicine and Biology Society, EMBC, 2011 Annual International Conference of the 
IEEE, 2011, pp. 2472–2475. 
  
 
94         Assessment of trends in the cardiovascular system 
[16] S  Laurent  J  Cockcroft  L  Van Bortel  P  Boutouyrie  C  Giannattasio  et al   “Expert 
Consensus Document on Arterial Stiffness: Methodological Issues and Clinical 
Applications ” Eur. Heart J., vol. 27, no. 21, pp. 2588–2605, Sep. 2006. 
[17] P. Boutouyrie  M  Briet  C  Collin  S  Vermeersch  and B  Pannier  “Assessment of Pulse 
Wave Velocity ” Artery Res., vol. 3, no. 1, pp. 3–8, Feb. 2009. 
[18] A  M  Weissler  W  S  Harris  and C  D  Schoenfeld  “Systolic Time Intervals in Heart 
Failure in Man ” Circulation, vol. 37, no. 2, pp. 149–159, 1968. 
[19] D  Buxi  J  M  Redouté  and M  R  Yuce  “A Survey on Signals and Systems in Ambulatory 
Blood Pressure Monitoring Using Pulse Transit Time ” Physiol. Meas., vol. 36, no. 3, pp. R1–
R26, Mar. 2015. 
[20] J. Naschitz, S. Bezobchuk, R. Mussafia-Priselac  S  Sundick  D  Dreyfuss  et al   “Pulse 
Transit Time by R-wave-gated Infrared Photoplethysmography: Review of the Literature 
and Personal Experience ” J. Clin. Monit. Comput., vol. 18, no. 5–6, pp. 333–342, Dec. 2004. 
[21] J. Argod, J.-L  Pépin  and P  Lévy  “Differentiating Obstructive and Central Sleep 
Respiratory Events through Pulse Transit Time ” Am. J. Respir. Crit. Care Med., vol. 158, no. 
6, pp. 1778–1783, Dec. 1998. 
[22] T. Weiss, A. Del Bo, N. Reichek, and K. Engelman  “Pulse Transit Time in the Analysis of 
Autonomic Nervous System Effects on the Cardiovascular System ” Psychophysiology, vol. 17, 
no. 2, pp. 202–207, Mar. 1980. 
[23] W  Chen  T  Kobayashi  S  Ichikawa  Y  Takeuchi  and T  Togawa  “Continuous Estimation 
of Systolic Blood Pressure Using the Pulse Arrival Time and Intermittent Calibration ” Med. 
Biol. Eng. Comput., vol. 38, no. 5, pp. 569–574, Sep. 2000. 
[24] H  Gesche  D  Grosskurth  G  Küchler  and A  Patzak  “Continuous Blood Pressure 
Measurement by Using the Pulse Transit Time: Comparison to a Cuff-based Method ” Eur. 
J. Appl. Physiol., vol. 112, no. 1, pp. 309–315, May 2012. 
[25] J. G. Kips, A. E. Schutte, S. J. Vermeersch, H. W. Huisman, J. M. Van Rooyen, et al., 
“Comparison of Central Pressure Estimates Obtained From SphygmoCor, Omron HEM-
9000AI and Carotid Applanation Tonometry ” J. Hypertens., vol. 29, no. 6, pp. 1115–1120, 
2011. 
[26] S  S  Ahmed  G  E  Levinson  C  J  Schwartz  and P  O  Ettinger  “Systolic Time Intervals as 
Measures of the Contractile State of the Left Ventricular Myocardium in Man ” Circulation, 
vol. 46, no. 3, pp. 559–571, Sep. 1972. 
[27] D  B  Newlin and R  W  Levenson  “Pre-ejection Period: Measuring Beta-adrenergic 
Influences Upon the Heart ” Psychophysiology, vol. 16, no. 6, pp. 546–552, Nov. 1979. 
[28] R  P  Lewis  S  E  Rittogers  W  F  Froester  and H  Boudoulas  “A Critical Review of the 
Systolic Time Intervals ” Circulation, vol. 56, no. 2, pp. 146–158, Aug. 1977. 
  
 
95 References 
[29] T. Weber, M. Ammer, M. Rammer, A. Adji, M. F. O’Rourke  et al   “Noninvasive 
Determination of Carotid–Femoral Pulse Wave Velocity Depends Critically on Assessment 
of Travel Distance: A Comparison with Invasive Measurement ” J. Hypertens., vol. 27, no. 8, 
pp. 1624–1630, Aug. 2009. 
[30] P. Salvi, E. Magnani  F  Valbusa  D  Agnoletti  C  Alecu  et al   “Comparative Study of 
Methodologies for Pulse Wave Velocity Estimation ” J. Hum. Hypertens., vol. 22, no. 10, pp. 
669–677, Oct. 2008. 
[31] N  A  Jatoi  A  Mahmud  K  Bennett  and J  Feely  “Assessment of Arterial Stiffness in 
Hypertension: Comparison of Oscillometric (Arteriograph), Piezoelectronic (Complior) and 
Tonometric (SphygmoCor) techniques* ” J. Hypertens., vol. 27, no. 11, 2009. 
[32] S. C. Millasseau, A. D. Stewart, S. J. Patel, S. R. Redwood, and P. J. Chowienczyk, 
“Evaluation of Carotid-femoral Pulse Wave Velocity: Influence of Timing Algorithm and 
Heart Rate ” Hypertension, vol. 45, no. 2, pp. 222–226, Feb. 2005. 
[33] M  Merri  D  C  Farden  J  G  Mottley  and E  L  Titlebaum  “Sampling Frequency of the 
Electrocardiogram for Spectral Analysis of the Heart Rate Variability ” Biomed. Eng. IEEE 
Trans., vol. 37, no. 1, pp. 99–106, Jan. 1990. 
[34] S  Mittal  C  Movsowitz  and J  S  Steinberg  “Ambulatory External Electrocardiographic 
Monitoring. Focus on Atrial Fibrillation ” J. Am. Coll. Cardiol., vol. 58, no. 17, pp. 1741–
1749, Oct. 2011. 
[35] American National Standards Institute  “Ambulatory Electrocardiographs (ANSI/AAMI 
EC38:1998) ” Arlington  VA: Association for the Advancement of Medical Instrumentation, 
1998. 
[36] American National Standards Institute  “Diagnostic Electrocardiographic Devices 
(ANSI/AAMI EC11:1991/(R)2001) ” Arlington  VA: Association for the Advancement of 
Medical Instrumentation, 2000. 
[37] A  Ueno  Y  Akabane  T  Kato  H  Hoshino  S  Kataoka  et al   “Capacitive Sensing of 
Electrocardiographic Potential Through Cloth From the Dorsal Surface of the Body in a 
Supine Position: A Preliminary Study ” Biomed. Eng. IEEE Trans., vol. 54, no. 4, pp. 759–
766, Apr. 2007. 
[38] A  S  and L  Kirkup  “A Direct Comparison of Wet  Dry and Insulating Bioelectric 
Recording Electrodes ” Physiol. Meas., vol. 21, no. 2, p. 271, 2000. 
[39] Y  M  Chi  T  P  Jung  and G  Cauwenberghs  “Dry-contact and Noncontact Biopotential 
Electrodes: Methodological Review ” Biomed. Eng. IEEE Rev., vol. 3, pp. 106–119, 2010. 
[40] P. S. Luna-Lozano and R. Pallas-Areny  “Microphonics in Biopotential Measurements With 
Capacitive Electrodes ” in Engineering in Medicine and Biology Society (EMBS), 2010. 32th Annual 
International Conference of the IEEE, Aug. 2010, pp. 3487–3490. 
  
 
96         Assessment of trends in the cardiovascular system 
[41] G  Ascher and J  P  Coustenoble  “Portable apparatus for recording electrocardiograms ” 
US Patent 4,596,256, Jun. 24th, 1986. 
[42] S. R. Inciardi, S. D. Elliott  F  Einberg  and K  Svensson  “eCard ECG Monitor ” US Patent 
Application 2014/0073979, Mar. 13th, 2014. 
[43] A  Benini  M  Donati  F  Iacopetti  and L  Fanucci  “User-friendly Single-lead ECG Device 
for Home Telemonitoring Applications ” in 2014 8th International Symposium on Medical 
Information and Communication Technology (ISMICT), Apr. 2014, pp. 1–5. 
[44] M  Kohls  “ECG Recording Device and Method of Use ” US Patent Application 
2007/0149886, Jun. 28th, 2007. 
[45] C  A  Chou  “Handheld Electrocardiographic Device ” US Patent 8 644 915 B2  Feb  4th  
2014. 
[46] H  L  Chan  P  K  Chao  and J  C  Jheng  “Device and method for measuring three-lead 
ECG in a wristwatch ” US Patent Application 2010/0076331  Mar  25th  2010  
[47] G. Andreoni, A. Pedotti, and M  Di Rienzo  “ECG Monitoring through Environmental 
Electrodes ” in 1st Annual International IEEE-EMBS Special Topic Conference on Microtechnologies 
in Medicine and Biology. Proceedings, 2000, pp. 615–618. 
[48] H  B  Wheeler  “Diagnosis of Deep Vein Thrombosis. Review of Clinical Evaluation and 
Impedance Plethysmography ” Am. J. Surg., vol. 150, no. 4A, pp. 7–13, 1985. 
[49] L  Jensen  J  Yakimets  and K  K  Teo  “A Review of Impedance Cardiography ” Hear. Lung 
J. Acute Crit. Care, vol. 24, no. 3, pp. 183–193, May 1995. 
[50] M. D. Reisner Andrew, P. D. Shaltis Phillip A., D. McCombie, and P. D. Asada H Harry, 
“Utility of the Photoplethysmogram in Circulatory Monitoring ” J. Am. Soc. Anesthesiol., vol. 
108, no. 5, pp. 950–958, May 2008. 
[51] T. M. R. Shankar  J  G  Webster  and S  Y  Shao  “The Contribution of Vessel Volume 
Change and Blood Resistivity Change to the Electrical Impedance Pulse ” Biomed. Eng. 
IEEE Trans., vol. BME-32, no. 3, pp. 192–198, Mar. 1985. 
[52] S. Bang, C. Lee, J. Park, M. C. Cho, Y. G  Yoon  et al   “A Pulse Transit Time Measurement 
Method Based on Electrocardiography and Bioimpedance ” in 2009 IEEE Biomedical Circuits 
and Systems Conference, Nov. 2009, pp. 153–156. 
[53] F. Risacher, J. Jossinet, E. McAdams, C. Eynard, J. McLaughlin, et al   “Computation of the 
Pulse Wave Velocity in Limbs From Multichannel Impedance Plethysmography ” in 
Engineering in Medicine and Biology Society (EMBS), 1992. 14th Annual International Conference of the 
IEEE, Oct. 1992, vol. 5, pp. 1744–1745. 
[54] B. A  Friedman  R  Medero  L  T  Hersh  and S  Kolluri  “Continuous  Non-invasive 
Technique for Measuring Blood Pressure Using Impedance Plethysmography ” U S  patent: 
US6648828 B2, issued, Nov. 18th, 2003. 
  
 
97 References 
[55] M  C  Cho  J  Y  Kim  and S  Cho  “A Bio-impedance Measurement System for Portable 
Monitoring of Heart Rate and Pulse Wave Velocity Using Small Body Area ” in 2009 IEEE 
International Symposium on Circuits and Systems, May 2009, pp. 3106–3109. 
[56] F. Risacher, J. Jossinet, E. T. McAdams, J. McLaughlin, Y  Mann  et al   “Impedance 
Plethysmography for the Evaluation of Pulse Wave Velocity in Limbs ” Med. Biol. Eng. 
Comput., vol. 31, no. 3, pp. 318–322, 1993. 
[57] N  K  Kristiansen  J  Fleischer  M  S  Jensen  K  S  Andersen  and H  Nygaard  “Design and 
Evaluation of a Handheld Impedance Plethysmograph for Measuring Heart Rate 
Variability ” Med. Biol. Eng. Comput., vol. 43, no. 4, pp. 516–521, 2005. 
[58] T  Kööbi  M  Kähönen  T  Iivainen  and V  Turjanmaa  “Simultaneous Non-invasive 
Assessment of Arterial Stiffness and Haemodynamics – A Validation Study ” Clin. Physiol. 
Funct. Imaging, vol. 23, no. 1, pp. 31–36, Jan. 2003. 
[59] K  R  Foster and H  C  Lukaski  “Whole-body Impedance - What Does It Measure? ” Am. J. 
Clin. Nutr., vol. 64, no. 3, p. 388S–396S, Sep. 1996. 
[60] D. H. Diaz, O. Casas, and R. Pallas-Areny  “Heart rate detection from single-foot plantar 
bioimpedance measurements in a weighing scale ” in Engineering in Medicine and Biology Society, 
2010. EMBS 2010. 32th Annual International Conference of the IEEE, 2010, pp. 6489–6492. 
[61] O. Casas and R. Pallas-Areny  “Signal to Noise Ratio in Bioelectrical Impedance 
Measurements Using Synchronous Sampling ” in Engineering in Medicine and Biology Society 
(EMBC), 1994 Annual International Conference of the IEEE, 1994, vol. 2, pp. 890–891. 
[62] J  W  Gordon  “Certain Molar Movements of the Human Body Produced by the Circulation 
of the Blood ” J. Anat. Physiol., vol. 11, no. Pt 3, pp. 533–536, Apr. 1877. 
[63] I. Starr, A. J. Rawson, H. A. Schroeder, and N. R. Joseph  “Studies on the Estimation of 
Cardiac Ouptut in Man  and of Abnormalities in Cardiac Function  From the Heart’s Recoil 
and the Blood's Impacts; the Ballistocardiogram ” Am. J. Physiol. - Leg. Content, vol. 127, no. 
1, pp. 1–28, 1939. 
[64] E. Pinheiro  O  Postolache  and P  Girão  “Theory and Developments in an Unobtrusive 
Cardiovascular System Representation: Ballistocardiography ” Open Biomed. Eng. J., vol. 4, 
pp. 201–216, Oct. 2010. 
[65] A. Akhbardeh, S. Junnila, M. Koivuluoma, T. Koivistoinen, V  Turjanmaa  et al   “Towards 
a Heart Disease Diagnosing System Based on Force Sensitive Chair’s Measurement  
Biorthogonal Wavelets and Neural Networks ” Eng. Appl. Artif. Intell., vol. 20, no. 4, pp. 
493–502, Jun. 2007. 
[66] R. Gonzalez-Landaeta, O. Casas, and R. Pallas-Areny  “Heart Rate Detection from an 
Electronic Weighing Scale ” in Engineering in Medicine and Biology Society (EMBS), 2007. 29th 
Annual International Conference of the IEEE, Aug. 2007, vol. 2007, pp. 6283–6. 
  
 
98         Assessment of trends in the cardiovascular system 
[67] J  Alihanka  K  Vaahtoranta  and I  Saarikivi  “A New Method for Long-term Monitoring of 
the Ballistocardiogram  Heart Rate  and Respiration ” Am. J. Physiol. - Regul. Integr. Comp. 
Physiol., vol. 240, no. 5, pp. R384–R392, May 1981. 
[68] P. F. Migeotte, Q  Deliere  J  Tank  I  Funtova  R  Baevsky  et al   “3D-ballistocardiography 
in Microgravity: Comparison With Ground Based Recordings ” Engineering in Medicine and 
Biology Society, 2011. EMBS 2012. 35th Annual International Conference of the IEEE. pp. 7012–
7016, 2013. 
[69] O  T  Inan  M  Etemadi  A  Paloma  L  Giovangrandi  and G  T  A  Kovacs  “Non-invasive 
Cardiac Output Trending During Exercise Recovery on a Bathroom-scale-based 
Ballistocardiograph ” Physiol. Meas., vol. 30, no. 3, p. 261, Feb. 2009. 
[70] O  T  Inan  M  Etemadi  R  M  Wiard  G  T  A  Kovacs  and L  Giovangrandi  “Non-
invasive Measurement of Valsalva-induced Hemodynamic Changes on a Bathroom Scale 
Ballistocardiograph ” Eng. Med. Biol. Soc. (EMBS), 2008. 30th Annu. Int. Conf. IEEE, vol. 
2008, pp. 674–7, Jan. 2008. 
[71] M  Etemadi  O  T  Inan  R  M  Wiard  G  T  A  Kovacs  and L  Giovangrandi  “Non-
invasive Assessment of Cardiac Contractility on a Weighing Scale ” in Engineering in Medicine 
and Biology Society (EMBS), 2009. 31th Annual International Conference of the IEEE, 2009, pp. 
6773–6776. 
[72] J  Muehlsteff  X  L  Aubert  and M  Schuett  “Cuffless Estimation of Systolic Blood Pressure 
for Short Effort Bicycle Tests: the Prominent Role of the Pre-ejection Period ” in Engineering 
in Medicine and Biology Society (EMBS), 2006. 28th Annual International Conference of the IEEE, 
2006, pp. 5088–5092. 
[73] I. Starr and A. Noordergraaf, Ballistocardiography in Cardiovascular Research: Physical Aspects of the 
Circulation in Health and Disease, 1st ed. Philadelphia: Lippincott, 1967. 
[74] M  Etemadi  O  T  Inan  L  Giovangrandi  and G  T  A  Kovacs  “Rapid Assessment of 
Cardiac Contractility on a Home Bathroom Scale ” Inf. Technol. Biomed. IEEE Trans., vol. 15, 
no. 6, pp. 864–869, Nov. 2011. 
[75] I. Starr  T  G  Schnabel  and R  L  Mayock  “Studies Made by Simulating Systole at 
Necropsy: II. Experiments on the Relation of Cardiac and Peripheral Factors to the Genesis 
of the Pulse Wave and the Ballistocardiogram ” Circulation, vol. 8, no. 1, pp. 44–61, Jul. 
1953. 
[76] C  S  Kim  A  M  Carek  R  Mukkamala  O  T  Inan  and J  O  Hahn  “Ballistocardiogram as 
Proximal Timing Reference for Pulse Transit Time Measurement: Potential for Cuffless 
Blood Pressure Monitoring ” Biomed. Eng. IEEE Trans., vol. PP, no. 99, p. 1, 2015. 
[77] A  D  Waller  “A Demonstration on Man of Electromotive Changes Accompanying the 
Heart’s Beat ” J. Physiol., vol. 8, no. 5, pp. 229–234, 1887. 
  
 
99 References 
[78] M. Rivera-Ruiz  C  Cajavilca  and J  Varon  “Einthoven’s String Galvanometer: the First 
Electrocardiograph  ” Tex. Heart Inst. J., vol. 35, no. 2, pp. 174–8, Jan. 2008. 
[79] J  C  Huhta and J  G  Webster  “60-Hz Interference in Electrocardiography ” Biomed. Eng. 
IEEE Trans., vol. 20, no. 2, pp. 91–101, Mar. 1973. 
[80] N  Meziane  J  G  Webster  M  Attari  and A  J  Nimunkar  “Dry Electrodes for 
Electrocardiography ” Physiol. Meas., vol. 34, no. 9, p. R47, 2013. 
[81] M  R  Neuman  “Biopotential Electrodes ” in Medical Instrumentation Application and Design, 
4th ed., J. G. Webster, Ed. New York, USA: John Wiley & Sons, 2009, pp. 189–240. 
[82] N  V Thakor and J  G  Webster  “Ground-Free ECG Recording with Two Electrodes ” 
Biomed. Eng. IEEE Trans., vol. BME-27, no. 12, pp. 699–704, 1980. 
[83] “Patient Safety ” Med  Electro  Div., Hewlett-Packard Co., Waltham, Mass., Appl. Note AN 
718, 1971. 
[84] D. Diaz, O. Casas, and R. Pallas-Areny  “Interference Reduction in ECG by Using a Dual 
Ground Electrode ” in 19th IMEKO World Congress 2009, 2009, pp. 1695–1700. 
[85] J. Pan and W. J. Tompkins  “A Real-time QRS Detection Algorithm ” Biomed. Eng. IEEE 
Trans., vol. 32, no. 3, pp. 230–236, Mar. 1985. 
[86] Joint Comitee for Guides in Metrology  “Evaluation of Measurement Data - Guide to the 
Expression of Uncertainty in Measurement (JCGM 100:2008) ” JGCM  2008  
[87] X  Zhou  R  Peng  H  Ding  N  Zhang  and P  Li  “Validation of New and Existing Decision 
Rules for the Estimation of Beat-to-Beat Pulse Transit Time ” Biomed Res. Int., vol. 2015, p. 
306934, Mar. 2015. 
[88] M. J. Drinnan, J. Allen  and A  Murray  “Relation Between Heart Rate and Pulse Transit 
Time During Paced Respiration ” Physiol. Meas., vol. 22, no. 3, pp. 425–432, 2001. 
[89] E. M. Spinelli, R. Pallas-Areny  and M  A  Mayosky  “AC-Coupled Front-End for 
Biopotential Measurements ” Biomed. Eng. IEEE Trans., vol. 50, no. 3, pp. 391–5, Mar. 2003. 
[90] C  Assambo and M  J  Burke  “Low-frequency Response and the Skin-electrode Interface in 
Dry-electrode Electrocardiography ” in Advances in Electrocardiograms - Methods and Analysis, R. 
M. Millis, Ed. INTECH Open Access Publisher, 2012. 
[91] D  Nunan  G  R  H  Sandercock  and D  A  Brodie  “A Quantitative Systematic Review of 
Normal Values for Short-Term Heart Rate Variability in Healthy Adults ” Pacing Clin. 
Electrophysiol., vol. 33, no. 11, pp. 1407–1417, Nov. 2010. 
[92] C  Y  Liu  C  C  Wei  and P  C  Lo  “Variation Analysis of Sphygmogram to Assess 
Cardiovascular System under Meditation ” Evid. Based. Complement. Alternat. Med., vol. 6, no. 
1, pp. 107–112, Mar. 2009. 
[93] R. S. Vasan, “Pathogenesis of Elevated Peripheral Pulse Pressure: Some Reflections and 
Thinking Forward ” Hypertension, vol. 51, no. 1, pp. 33–36, Jan. 2008. 
  
 
100         Assessment of trends in the cardiovascular system 
[94] A  A  Alian and K  H  Shelley  “Photoplethysmography ” Best Pract. Res. Clin. Anaesthesiol., 
vol. 28, no. 4, pp. 395–406, Apr. 2015. 
[95] R  A  Peura  “Blood Pressure and Sound ” in Medical Instrumentation Application and Design, 4th 
ed., J. G. Webster, Ed. New York, USA: John Wiley & Sons, 2009, pp. 293–337. 
[96] J  Allen and A  Murray  “Effects of Filtering on Multi-site Photoplethysmography Pulse 
Waveform Characteristics ” in Computers in Cardiology, 2004, 2004, pp. 485–488. 
[97] American National Standards Institute  “Safe Current Limits for Electromedical Apparatus 
(ANSI/AAMI ES1:1993) ” Arlington  VA: Association for the Advancement of Medical 
Instrumentation, 1993. 
[98] R  V Hill  J  C  Jansen  and J  L  Fling  “Electrical Impedance Plethysmography: A Critical 
Analysis ” J. Appl. Physiol., vol. 22, no. 1, pp. 161–168, 1967. 
[99] B. H. Brown, A. J. Wilson, and P. Bertemes-Filho  “Bipolar and Tetrapolar Transfer 
Impedance Measurements from Volume Conductor ” Electron. Lett., vol. 36, no. 25, pp. 
2060–2062, 2000. 
[100] R. Pallas-Areny and J  G  Webster  “AC Instrumentation Amplifier for Bioimpedance 
Measurements ” Biomed. Eng. IEEE Trans., vol. 40, no. 8, pp. 830–833, 1993. 
[101] R  S  Gubner  M  Rodstein  and H  E  Ungerleider  “Ballistocardiography: an Appraisal of 
Technic  Physiologic Principles  and Clinical Value ” Circulation, vol. 7, no. 2, pp. 268–286, 
Feb. 1953. 
[102] A  Noordergraaf  “Further Studies on a Theory of the Ballistocardiogram ” Circulation, vol. 
23, no. 3, pp. 413–425, Mar. 1961. 
[103] J  R  Braunstein  C  E  Oelker  and R  C  Gowdy  “Design of a Two-dimensional 
Ballistocardiograph ” J. Clin. Invest., vol. 29, no. 9, pp. 1219–1226, Sep. 1950. 
[104] M  B  Rappaport  H  B  Sprague  and W  B  Thompson  “Ballistocardiography - I. Physical 
Considerations ” Circulation, vol. 7, no. 2, pp. 229–246, Feb. 1953. 
[105] N  T  Smith  “Ballistocardiography ” in Noninvasive Cardiology, A. M. Weissler, Ed. New 
York, USA: Grune & Stratton, 1974, pp. 39–148. 
[106] O  T  Inan  M  Etemadi  R  M  Wiard  L  Giovangrandi  and G  T  A  Kovacs  “Robust 
Ballistocardiogram Acquisition for Home Monitoring ” Physiol. Meas., vol. 30, no. 2, p. 169, 
2009. 
[107] O  T  Inan  “Novel Technologies for Cardiovascular Monitoring Using Ballistocardiography 
and Electrocardiography ” ProQuest LLC  2009  
[108] O  T  Inan and G  T  A  Kovacs  “A Low-noise AC-bridge Amplifier for Ballistocardiogram 
Measurement on an Electronic Weighing Scale ” Physiol. Meas., vol. 31, no. 7, p. N51, 2010. 
[109] J  H  Shin and K  S  Park  “HRV Analysis and Blood Pressure Monitoring on Weighing 
Scale Using BCG ” in Engineering in Medicine and Biology Society (EMBC), 2012 Annual 
International Conference of the IEEE, 2012, pp. 3789–3792. 
  
 
101 References 
[110] C  Woody  “Characterization of an Adaptive Filter for the Analysis of Variable Latency 
Neuroelectric Signals ” Med. Biol. Eng., vol. 5, no. 6, pp. 539–554, 1967. 
[111] S. Grimnes and O. G. Martinsen, Bioimpedance and Bioelectricity Basics, 2nd ed. Amsterdam, 
The Netherlands, 2008. 
[112] L  Waite  “Anatomy and Physiology of Blood Vessels ” in Biofluid Mechanics in Cardiovascular 
Systems, 1st ed., New York: Mc Graw Hill, 2006, pp. 89–104. 
[113] M. N. Levy and A. J. Pappano, Cardiovascular Physiology, 9th ed. Philadelphia, USA: Mosby, 
Inc., 2007. 
[114] J  J  Wang and K  H  Parker  “Wave Propagation in a Model of the Arterial Circulation ” J. 
Biomech., vol. 37, no. 4, pp. 457–470, Apr. 2004. 
[115] P  Reymond  F  Merenda  F  Perren  D  Rüfenacht  and N  Stergiopulos  “Validation of a 
One-dimensional Model of the Systemic Arterial Tree ” Am. J. Physiol. - Hear. Circ. Physiol., 
vol. 297, no. 1, pp. H208–H222, Jun. 2009. 
[116] J  C  Bramwell and A  V Hill  “The Velocity of the Pulse Wave in Man ” Proc. R. Soc. London. 
Ser. B, Contain. Pap. a Biol. Character, vol. 93, no. 652, pp. 298–306, Apr. 1922. 
[117] J  Sola  R  Vetter  P  Renevey  O  Chetelat  C  Sartori  et al   “Parametric Estimation of Pulse 
Arrival Time: A Robust Approach to Pulse Wave Velocity ” Physiol. Meas., vol. 30, no. 7, pp. 
603–615, Jul. 2009. 
[118] D  A  McDonald  W  W  Nichols  and M  F  O’Rourke  McDonald’s Blood Flow in Arteries. 
Theoretical, Experimental, and Clinical Principles, 5th ed. London, UK: Arnold, 2005. 
[119] D  H  Spodick and V  Q  Lance  “Noninvasive Stress Testing  Methodology for Elimination 
of the Phonocardiogram ” Circulation, vol. 53, no. 4, pp. 673–676, 1976. 
[120] D  B  Newlin  “Relationships of Pulse Transmission Times to Pre-ejection Period and 
Blood Pressure ” Psychophysiology, vol. 18, no. 3, pp. 316–321, 1981. 
[121] I  B  Wilkinson  S  S  Franklin  I  R  Hall  S  Tyrrell  and J  R  Cockcroft  “Pressure 
Amplification Explains Why Pulse Pressure Is Unrelated to Risk in Young Subjects ” 
Hypertension, vol. 38, no. 6, pp. 1461–1466, Dec. 2001. 
[122] F. Van de Werf, J. Piessens  H  Kesteloot  and H  De Geest  “A Comparison of Systolic 
Time Intervals Derived From the Central Aortic Pressure and From the External Carotid 
Pulse Tracing ” Circulation, vol. 51, no. 2, pp. 310–316, Feb. 1975. 
[123] D  Park  O  T  Inan  and L  Giovangrandi  “A Combined Heartbeat Detector Based on 
Individual BCG and IPG Heartbeat Detectors ” in Engineering in Medicine and Biology Society 
(EMBC), 2012 Annual International Conference of the IEEE, 2012, pp. 3428–3431. 
[124] O  T  Inan  D  Park  L  Giovangrandi  and G  T  A  Kovacs  “Noninvasive Measurement of 
Physiological Signals on a Modified Home Bathroom Scale ” Biomed. Eng. IEEE Trans., vol. 
59, no. 8, pp. 2137–2143, Aug. 2012. 
  
 
102         Assessment of trends in the cardiovascular system 
[125] S. Préau, F. Dewavrin, V. Soland, P  Bortolotti  D  Colling  et al   “Hemodynamic Changes 
During a Deep Inspiration Maneuver Predict Fluid Responsiveness in Spontaneously 
Breathing Patients ” Cardiol. Res. Pract., vol. 2012, no. 191807, pp. 1–8, Sep. 2011. 
[126] J. Filipovsky, O. Mayer, M. Dolejsova  and J  Seidlerova  “The Assessment of Carotid–
Femoral Distance for Aortic Pulse Wave Velocity: Should it Be Estimated from Body 
Height? ” Artery Res., vol. 4, no. 1, pp. 19–23, Feb. 2010.  
 
  
 
103 References 
Summary of research contributions 
The novelties presented on this thesis have been disseminated through 2 journal papers, 1 
patent, and 7 conference papers. The following summary relates the published results to the work 
described on each chapter.  
 
Chapter 2: 2 journal papers and 4 conference papers. 
[C1] J. Gomez-Clapers, E. Serrano-Finetti, R. Casanella, and R. Pallas-Areny  “Can Driven-Right-
Leg Circuits Increase Interference in ECG Amplifiers? ” in Engineering in Medicine and Biology 
Society (EMBS), 2011. 33th Annual International Conference of the IEEE, 2011, pp. 4780–4783. 
[J1] J. Gomez-Clapers  and R  Casanella  “A Fast and Easy-to-Use ECG Acquisition and Heart 
Rate Monitoring System Using a Wireless Steering Wheel ” Sensors Journal, IEEE, vol. 12, no. 
3, pp. 610-616, Mar. 2012. 
[C2] J. Gomez-Clapers, R. Casanella, and R. Pallas-Areny  “Multi-Signal Bathroom Scale to Assess 
Long-Term Trends in Cardiovascular Parameters ” in Engineering in Medicine and Biology Society 
(EMBS), 2012. 34th Annual International Conference of the IEEE, 2012, pp. 550–553. 
[C3] J. Gomez-Clapers, R. Casanella, and R. Pallas-Areny  “Obtención de parámetros 
cardiovasculares en una báscula electrónica doméstica ” in XXX Congreso Anual de la Sociedad 
Española de Ingeniería Biomédica CASEIB 2012, 2012. 
[C4] J. Gomez-Clapers, A. Serra-Rocamora, R. Casanella, and R. Pallas-Areny  “Uncertainty 
Factors in Time-Interval Measurements in Ballistocardiography ” in 19th Symposium IMEKO 
TC 4 and 17th IWADC Workshop, 2013. 
[J2] J. Gomez-Clapers, A. Serra-Rocamora, R. Casanella, and R. Pallas-Areny  “Towards the 
Standardization of Ballistocardiography Systems for J-Peak Timing Measurement ” 
Measurement, vol. 58, pp. 310–316, Dec. 2014. 
 
Chapter 3: 1 conference paper and 1 patent. 
[C5] J. Gomez-Clapers, R. Casanella, and R. Pallas-Areny  “Pulse Arrival Time Estimation from 
the Impedance Plethysmogram ” in Engineering in Medicine and Biology Society (EMBS), 2011. 
33th Annual International Conference of the IEEE, 2011, pp. 516–519. 
[P1] R. Pallas-Areny, R. Casanella, and J. Gomez-Clapers  “Method and Apparatus for Obtaining 
Cardiovascular Information by Measuring Between Two Extremities ” W O  patent 
WO2013017718 A2, issued, Feb. 7th 2013. 
 
Chapter 4: 2 conference papers. 
[C6] J. Gomez-Clapers, R. Casanella, and R. Pallas-Areny  “Seguimiento de cambios 
hemodinámicos mediante la detección del intervalo RJ en tiempo real ” in XXVIII Congreso 
Anual de la Sociedad Española de Ingeniería Biomédica CASEIB 2010, 2010. 
  
 
104         Assessment of trends in the cardiovascular system 
[C7] R. Casanella, J. Gomez-Clapers, and R. Pallas-Areny  “On Time Interval Measurements 
Using BCG ” in Engineering in Medicine and Biology Society (EMBS), 2012. 34th Annual 
International Conference of the IEEE, 2012, pp. 5034–5037. 
 
During the development of this thesis the author the author has collaborated on the following 
publications: 
[C8] J. Gomez-Clapers  and R  Casanella  “Wireless ECG and Heart Rate Monitoring Using Dual 
Ground Dry Electrodes ” in 17th Symposium IMEKO TC 4, 2010. 
[C9] S. Gilaberte, J. Gomez-Clapers, R. Casanella, and R. Pallas-Areny  “Heart and Respiratory 
Rate Detection on a Bathroom Scale Based on the Ballistocardiogram and the Continuous 
Wavelet Transform ” in Engineering in Medicine and Biology Society (EMBS), 2010. 32th Annual 
International Conference of the IEEE, 2010, pp. 2557–2560. 
[P2] R. Pallas-Areny, O. Casas, R. Casanella, J. Gomez-Clapers  and D  Diaz  “Método y aparato 
para obtener el electrocardiograma mediante electrodos secos dobles ” W O  Patent 
WO2011104398, issued, Sep. 1st 2011. 
 
  
 
 
 
 
 
 
 
 
 
The Shawshank Redemption (1994) 
